Implementation	O
findings	O
from	O
a	O
hybrid	O
III	O
implementation	O
-	O
effectiveness	O
trial	O
of	O
the	O
Diabetes	B-DS
Prevention	O
Program	O
(	O
DPP	O
)	O
in	O
the	O
Veterans	O
Health	O
Administration	O
(	O
VHA	O
)	O

Background	O

The	O
Diabetes	B-DS
Prevention	O
Program	O
(	O
DPP	O
)	O
is	O
an	O
effective	O
lifestyle	O
intervention	O
to	O
reduce	O
incidence	O
of	O
type	B-DS
2	I-DS
diabetes	I-DS
.	O

However	O
,	O
there	O
are	O
gaps	O
in	O
knowledge	O
about	O
how	O
to	O
implement	O
DPP	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
implementation	O
of	O
DPP	O
via	O
assessment	O
of	O
a	O
clinical	O
demonstration	O
in	O
the	O
Veterans	O
Health	O
Administration	O
(	O
VHA	O
).	O

Methods	O

A	O
12	O
-	O
month	O
pragmatic	O
clinical	O
trial	O
compared	O
weight	O
outcomes	O
between	O
the	O
Veterans	O
Affairs	O
Diabetes	B-DS
Prevention	O
Program	O
(	O
VA	O
-	O
DPP	O
)	O
and	O
the	O
usual	O
care	O
MOVE	O
!®	O
weight	O
management	O
program	O
(	O
MOVE	O
!).	O

Eligible	O
participants	O
had	O
a	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
≥	O
30	O
kg	O
/	O
m2	O
(	O
or	O
BMI	O
≥	O
25	O
kg	O
/	O
m2	O
with	O
one	O
obesity	B-DS
-	O
related	O
condition	O
),	O
prediabetes	B-DS
(	O
glycosylated	O
hemoglobin	B-GP
(	O
HbA1c	O
)	O
5	O
.	O
7	O
–	O
6	O
.	O
5	O
%	O
or	O
fasting	O
plasma	O
glucose	O
(	O
FPG	O
)	O
100	O
–	O
125	O
mg	O
/	O
dL	O
),	O
lived	O
within	O
60	O
min	O
of	O
their	O
VA	O
site	O
,	O
and	O
had	O
not	O
participated	O
in	O
a	O
weight	O
management	O
program	O
within	O
the	O
last	O
year	O
.	O

Established	O
evaluation	O
and	O
implementation	O
frameworks	O
were	O
used	O
to	O
guide	O
the	O
implementation	O
evaluation	O
.	O

Implementation	O
barriers	O
and	O
facilitators	O
,	O
delivery	O
fidelity	O
,	O
participant	O
satisfaction	O
,	O
and	O
implementation	O
costs	O
were	O
assessed	O
.	O

Using	O
micro	O
-	O
costing	O
methods	O
,	O
costs	O
for	O
assessment	O
of	O
eligibility	O
and	O
scheduling	O
and	O
maintaining	O
adherence	O
per	O
participant	O
,	O
as	O
well	O
as	O
cost	O
of	O
delivery	O
per	O
session	O
,	O
were	O
also	O
assessed	O
.	O

Results	O

Several	O
barriers	O
and	O
facilitators	O
to	O
Reach	O
,	O
Adoption	O
,	O
Implementation	O
,	O
Effectiveness	O
and	O
Maintenance	O
were	O
identified	O
;	O
barriers	O
related	O
to	O
Reach	O
were	O
the	O
largest	O
challenge	O
encountered	O
by	O
site	O
teams	O
.	O

Fidelity	O
was	O
higher	O
for	O
VA	O
-	O
DPP	O
delivery	O
compared	O
to	O
MOVE	O
!	O
for	O
five	O
of	O
seven	O
domains	O
assessed	O
.	O

Participant	O
satisfaction	O
was	O
high	O
in	O
both	O
programs	O
,	O
but	O
higher	O
in	O
VA	O
-	O
DPP	O
for	O
most	O
items	O
.	O

Based	O
on	O
micro	O
-	O
costing	O
methods	O
,	O
cost	O
of	O
assessment	O
for	O
eligibility	O
was	O
$	O
68	O
/	O
individual	O
assessed	O
,	O
cost	O
of	O
scheduling	O
and	O
maintaining	O
adherence	O
was	O
$	O
328	O
/	O
participant	O
,	O
and	O
cost	O
of	O
delivery	O
was	O
$	O
101	O
/	O
session	O
.	O

Conclusions	O

Multi	O
-	O
faceted	O
strategies	O
are	O
needed	O
to	O
reach	O
targeted	O
participants	O
and	O
successfully	O
implement	O
DPP	O
.	O

Costs	O
for	O
assessing	O
patients	O
for	O
eligibility	O
need	O
to	O
be	O
carefully	O
considered	O
while	O
still	O
maximizing	O
reach	O
to	O
the	O
targeted	O
population	O
.	O

Background	O

Incidence	O
of	O
type	B-DS
2	I-DS
diabetes	I-DS
(	O
referred	O
to	O
as	O
diabetes	B-DS
throughout	O
)	O
was	O
reduced	O
so	O
dramatically	O
(	O
by	O
58	O
%)	O
in	O
a	O
landmark	O
trial	O
of	O
the	O
Diabetes	B-DS
Prevention	O
Program	O
(	O
DPP	O
)	O
in	O
the	O
USA	O
that	O
the	O
trial	O
was	O
stopped	O
early	O
in	O
2001	O
[	O
1	O
–	O
4	O
].	O

Since	O
the	O
original	O
trial	O
,	O
many	O
large	O
-	O
scale	O
translations	O
around	O
the	O
world	O
,	O
including	O
Finland	O
,	O
Australia	O
,	O
China	O
,	O
and	O
India	O
,	O
have	O
successfully	O
reduced	O
onset	O
of	O
diabetes	B-DS
among	O
patients	O
with	O
prediabetes	B-DS
and	O
/	O
or	O
predictors	O
like	O
weight	O
loss	O
[	O
5	O
].	O

To	O
gain	O
an	O
overall	O
perspective	O
of	O
the	O
effectiveness	O
of	O
diabetes	B-DS
prevention	O
studies	O
,	O
Balk	O
et	O
al	O
.	O
conducted	O
a	O
review	O
of	O
53	O
studies	O
(	O
72	O
%	O
of	O
which	O
were	O
randomized	O
controlled	O
trials	O
),	O
evaluating	O
66	O
combined	O
diet	O
and	O
physical	O
activity	O
programs	O
(	O
41	O
%	O
of	O
which	O
were	O
based	O
on	O
DPP	O
),	O
and	O
concluded	O
that	O
such	O
programs	O
are	O
effective	O
in	O
reducing	O
incidence	O
of	O
diabetes	B-DS
,	O
body	O
weight	O
,	O
and	O
FPG	O
[	O
6	O
].	O

Programs	O
varied	O
widely	O
in	O
design	O
:	O
ranging	O
from	O
3	O
to	O
72	O
months	O
in	O
duration	O
and	O
from	O
no	O
contacts	O
(	O
virtual	O
contacts	O
only	O
)	O
up	O
to	O
72	O
contacts	O
with	O
participants	O
.	O

The	O
review	O
concluded	O
that	O
more	O
intensive	O
programs	O
appeared	O
to	O
yield	O
more	O
positive	O
outcomes	O
,	O
but	O
there	O
was	O
little	O
insight	O
into	O
how	O
other	O
program	O
characteristics	O
may	O
contribute	O
to	O
outcomes	O
.	O

Since	O
these	O
studies	O
focused	O
on	O
patient	O
outcomes	O
,	O
they	O
also	O
provided	O
no	O
insight	O
into	O
how	O
to	O
successfully	O
implement	O
these	O
interventions	O
.	O

Aziz	O
et	O
al	O
.	O
partially	O
filled	O
this	O
gap	O
with	O
their	O
systematic	O
review	O
of	O
38	O
studies	O
with	O
the	O
goal	O
of	O
identifying	O
factors	O
leading	O
to	O
successful	O
implementation	O
of	O
DPP	O
in	O
“	O
real	O
-	O
world	O
”	O
settings	O
[	O
7	O
]	O
using	O
the	O
penetration	O
,	O
implementation	O
,	O
participation	O
,	O
and	O
effectiveness	O
(	O
PIPE	O
)	O
impact	O
metric	O
.	O

Figure	O
1	O
shows	O
the	O
distribution	O
of	O
program	O
characteristics	O
for	O
eight	O
dimensions	O
and	O
two	O
outcomes	O
:	O
a	O
wide	O
range	O
of	O
program	O
designs	O
and	O
durations	O
have	O
been	O
implemented	O
within	O
clinical	O
and	O
community	O
settings	O
around	O
the	O
world	O
.	O

Across	O
this	O
diverse	O
array	O
of	O
studies	O
,	O
two	O
thirds	O
reported	O
low	O
participation	O
and	O
42	O
%	O
reported	O
low	O
weight	O
loss	O
(<	O
4	O
.	O
6	O
kg	O
)	O
[	O
7	O
].	O

Both	O
reviews	O
by	O
Aziz	O
et	O
al	O
.	O
and	O
Balk	O
et	O
al	O
.	O
concluded	O
that	O
more	O
intensive	O
programs	O
may	O
enhance	O
weight	O
loss	O
outcomes	O
.	O

However	O
,	O
Aziz	O
et	O
al	O
.	O
stress	O
that	O
even	O
modest	O
weight	O
loss	O
can	O
have	O
significant	O
population	O
-	O
level	O
impact	O
if	O
a	O
high	O
proportion	O
of	O
high	O
-	O
risk	O
individuals	O
participate	O
in	O
the	O
program	O
[	O
7	O
].	O

This	O
broader	O
view	O
of	O
impact	O
is	O
essential	O
for	O
policy	O
-	O
and	O
other	O
decision	O
-	O
making	O
.	O
Fig	O
.	O
1DPP	O
characteristics	O
reported	O
by	O
Aziz	O
et	O
al	O
.’	O
s	O
systematic	O
review	O
.	O

A	O
red	O
box	O
indicates	O
category	O
for	O
VA	O
-	O
DPP	O
.	O
aWorkplace	O
and	O
primary	O
care	O
settings	O
.	O
bCommunity	O
,	O
church	O
,	O
YMCA	O
,	O
various	O
venues	O
,	O
leisure	O
,	O
and	O
community	O
settings	O
.	O
cHealth	O
care	O
facilities	O
,	O
outpatient	O
settings	O
,	O
hospitals	O
.	O
dOther	O
modes	O
include	O
telephone	O
,	O
fax	O
,	O
text	O
,	O
email	O
,	O
online	O
.	O
eThirty	O
-	O
nine	O
studies	O
reported	O
because	O
one	O
study	O
reported	O
low	O
and	O
high	O
sites	O
.	O
fStandard	O
curriculum	O
=	O
delivery	O
of	O
DPP	O
following	O
a	O
standard	O
curriculum	O
.	O
gQA	O
=	O
quality	O
assurance	O
=	O
use	O
of	O
measures	O
to	O
monitor	O
implementation	O

Kahn	O
and	O
Davidson	O
[	O
8	O
]	O
highlighted	O
the	O
dearth	O
of	O
real	O
-	O
world	O
confirmation	O
of	O
the	O
remarkable	O
clinical	O
outcomes	O
reported	O
by	O
the	O
original	O
DPP	O
study	O
[	O
4	O
].	O

The	O
Balk	O
et	O
al	O
.	O
review	O
of	O
DPP	O
-	O
like	O
programs	O
reported	O
significant	O
reduction	O
in	O
diabetes	B-DS
incidence	O
(	O
0	O
.	O
59	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
52	O
–	O
0	O
.	O
66	O
,	O
based	O
on	O
16	O
(	O
30	O
%)	O
of	O
53	O
studies	O
that	O
reported	O
this	O
outcome	O
)	O
[	O
6	O
].	O

Aziz	O
et	O
al	O
.	O
reported	O
“	O
moderate	O
”	O
or	O
“	O
high	O
”	O
risk	O
reduction	O
for	O
7	O
(	O
18	O
%)	O
of	O
38	O
studies	O
;	O
this	O
outcome	O
was	O
“	O
unknown	O
”	O
for	O
the	O
remaining	O
31	O
(	O
82	O
%)	O
of	O
studies	O
[	O
7	O
].	O

The	O
low	O
proportion	O
of	O
studies	O
reporting	O
these	O
clinical	O
outcomes	O
may	O
indicate	O
potential	O
reporting	O
bias	O
toward	O
positive	O
results	O
;	O
on	O
the	O
other	O
hand	O
,	O
these	O
downstream	O
effects	O
are	O
more	O
challenging	O
to	O
assess	O
within	O
clinical	O
settings	O
outside	O
of	O
highly	O
controlled	O
lengthy	O
clinical	O
trials	O
.	O

Despite	O
the	O
“	O
voltage	O
drop	O
”	O
[	O
9	O
]	O
often	O
seen	O
in	O
outcomes	O
within	O
real	O
-	O
world	O
settings	O
,	O
definitive	O
guideline	O
statements	O
have	O
been	O
disseminated	O
recommending	O
DPP	O
around	O
the	O
world	O
[	O
10	O
–	O
12	O
].	O

Despite	O
large	O
-	O
scale	O
population	O
-	O
based	O
availability	O
of	O
DPP	O
in	O
some	O
countries	O
(	O
Finland	O
being	O
a	O
notable	O
leader	O
[	O
13	O
]),	O
within	O
other	O
countries	O
,	O
access	O
to	O
DPP	O
is	O
limited	O
,	O
in	O
part	O
because	O
of	O
the	O
expense	O
,	O
lack	O
of	O
reimbursement	O
by	O
insurance	O
or	O
funding	O
entities	O
,	O
and	O
challenges	O
of	O
effectively	O
implementing	O
DPP	O
across	O
diverse	O
uncontrolled	O
settings	O
and	O
populations	O
[	O
14	O
–	O
17	O
].	O

Within	O
the	O
USA	O
,	O
interest	O
in	O
implementing	O
DPP	O
is	O
increasing	O
because	O
the	O
US	O
Centers	O
of	O
Medicare	O
and	O
Medicaid	O
Services	O
(	O
CMS	O
)	O
plans	O
to	O
reimburse	O
participation	O
expenses	O
for	O
eligible	O
individuals	O
starting	O
in	O
2018	O
[	O
18	O
];	O
over	O
1000	O
programs	O
were	O
listed	O
in	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
(	O
CDC	O
)	O
registry	O
of	O
certified	O
programs	O
[	O
19	O
]	O
as	O
of	O
November	O
2016	O
compared	O
to	O
500	O
in	O
May	O
2014	O
[	O
12	O
].	O

In	O
the	O
USA	O
,	O
recognition	O
status	O
by	O
the	O
CDC	O
Diabetes	B-DS
Prevention	O
Recognition	O
Status	O
(	O
DPRP	O
)	O
requires	O
at	O
least	O
50	O
%	O
of	O
participants	O
to	O
have	O
a	O
diagnosis	O
of	O
prediabetes	B-DS
based	O
on	O
blood	O
testing	O
(	O
or	O
have	O
documented	O
history	O
of	O
gestational	B-DS
diabetes	I-DS
)	O
[	O
20	O
],	O
though	O
risk	O
assessments	O
,	O
administered	O
by	O
short	O
surveys	O
,	O
are	O
also	O
available	O
[	O
21	O
–	O
30	O
].	O

When	O
eligible	O
individuals	O
are	O
identified	O
,	O
outreach	O
is	O
needed	O
to	O
encourage	O
participation	O
in	O
DPP	O
and	O
often	O
clinical	O
testing	O
is	O
used	O
to	O
verify	O
diagnosis	O
.	O

Thus	O
,	O
significant	O
challenges	O
remain	O
:	O
designing	O
and	O
reliably	O
executing	O
robust	O
approaches	O
to	O
identify	O
,	O
enroll	O
,	O
and	O
engage	O
individuals	O
at	O
high	O
risk	O
for	O
diabetes	B-DS
.	O

Within	O
VA	O
,	O
the	O
national	O
policy	O
office	O
responsible	O
for	O
prevention	O
efforts	O
,	O
the	O
National	O
Center	O
for	O
Health	O
Promotion	O
and	O
Disease	O
Prevention	O
(	O
NCP	O
),	O
commissioned	O
a	O
pragmatic	O
trial	O
to	O
demonstrate	O
impact	O
and	O
feasibility	O
of	O
implementing	O
DPP	O
(	O
VA	O
-	O
DPP	O
)	O
in	O
VHA	O
,	O
in	O
the	O
context	O
of	O
the	O
already	O
existing	O
MOVE	O
!®	O
weight	O
management	O
program	O
(	O
MOVE	O
!)	O
[	O
31	O
].	O

This	O
clinical	O
demonstration	O
was	O
conducted	O
in	O
three	O
geographically	O
diverse	O
medical	O
centers	O
[	O
31	O
].	O

Candidate	O
participants	O
included	O
patients	O
with	O
prediabetes	B-DS
(	O
HbA1c	O
5	O
.	O
7	O
–	O
6	O
.	O
4	O
%	O
or	O
FPG	O
100	O
–	O
125	O
mg	O
/	O
dL	O
)	O
who	O
lived	O
within	O
60	O
min	O
of	O
a	O
demonstration	O
site	O
,	O
were	O
obese	O
(	O
BMI	O
>	O
30	O
kg	O
/	O
m2	O
)	O
or	O
overweight	O
(	O
BMI	O
25	O
–	O
30	O
kg	O
/	O
m2	O
)	O
with	O
diagnosis	O
of	O
an	O
obesity	B-DS
-	O
related	O
condition	O
(	O
e	O
.	O
g	O
.,	O
hypertension	B-DS
,	O
diabetes	B-DS
),	O
and	O
attended	O
a	O
MOVE	O
!	O
orientation	O
session	O
.	O

Eligibility	O
criteria	O
were	O
confirmed	O
clinically	O
;	O
participants	O
who	O
did	O
not	O
have	O
a	O
HbA1c	O
or	O
FPG	O
within	O
prior	O
6	O
months	O
were	O
invited	O
to	O
have	O
HbA1c	O
screening	O
,	O
which	O
is	O
aligned	O
with	O
CDC	O
DPP	O
and	O
national	O
care	O
guidelines	O
[	O
32	O
,	O
33	O
].	O

Patients	O
for	O
whom	O
anti	O
-	O
glycemic	O
medication	O
(	O
including	O
metformin	O
)	O
was	O
documented	O
within	O
their	O
electronic	O
health	O
record	O
in	O
the	O
last	O
6	O
months	O
and	O
those	O
with	O
contraindications	O
to	O
uptake	O
of	O
intensive	O
lifestyle	O
change	O
were	O
excluded	O
.	O

VA	O
-	O
DPP	O
characteristics	O
are	O
indicated	O
in	O
comparison	O
to	O
the	O
Aziz	O
et	O
al	O
.	O
review	O
in	O
Fig	O
.	O
1	O
.	O

In	O
an	O
intention	O
-	O
to	O
-	O
treat	O
analysis	O
,	O
participants	O
in	O
two	O
study	O
arms	O
(	O
VA	O
-	O
DPP	O
,	O
usual	O
care	O
weight	O
management	O
program	O
)	O
experienced	O
significant	O
weight	O
loss	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Participants	O
in	O
VA	O
-	O
DPP	O
lost	O
significantly	O
more	O
weight	O
at	O
6	O
months	O
compared	O
to	O
those	O
in	O
MOVE	O
!	O

(	O
4	O
.	O
1	O
vs	O
.	O
1	O
.	O
9	O
kg	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
but	O
the	O
difference	O
between	O
programs	O
was	O
no	O
longer	O
statistically	O
significant	O
(	O
3	O
.	O
4	O
vs	O
.	O
2	O
.	O
0	O
kg	O
,	O
p	O
=	O
0	O
.	O
16	O
)	O
at	O
12	O
months	O
[	O
34	O
].	O

Reach	O
was	O
higher	O
for	O
VA	O
-	O
DPP	O
compared	O
to	O
MOVE	O
!:	O
more	O
participants	O
assigned	O
to	O
VA	O
-	O
DPP	O
completed	O
at	O
least	O
one	O
session	O
(	O
73	O
%)	O
compared	O
to	O
those	O
assigned	O
to	O
MOVE	O
!	O

(	O
58	O
%;	O
p	O
=	O
0	O
.	O
002	O
)	O
[	O
34	O
].	O

VA	O
-	O
DPP	O
also	O
had	O
higher	O
rates	O
of	O
participation	O
,	O
e	O
.	O
g	O
.,	O
42	O
.	O
5	O
%	O
completed	O
at	O
least	O
eight	O
sessions	O
compared	O
to	O
31	O
%	O
for	O
MOVE	O
!.	O

Neither	O
VA	O
-	O
DPP	O
nor	O
MOVE	O
!	O
resulted	O
in	O
changed	O
HbA1c	O
compared	O
to	O
baseline	O
[	O
34	O
];	O
this	O
trial	O
was	O
not	O
powered	O
to	O
examine	O
differences	O
in	O
diabetes	B-DS
incidence	O
.	O

This	O
evaluation	O
was	O
guided	O
by	O
the	O
Reach	O
,	O
Effectiveness	O
,	O
Adoption	O
,	O
Implementation	O
,	O
and	O
Maintenance	O
(	O
RE	O
-	O
AIM	O
)	O
framework	O
,	O
which	O
was	O
designed	O
to	O
inform	O
translation	O
of	O
evidence	O
-	O
based	O
programs	O
into	O
practice	O
and	O
heighten	O
public	O
health	O
impact	O
by	O
examining	O
impact	O
on	O
domains	O
beyond	O
clinical	O
outcomes	O
[	O
35	O
,	O
36	O
].	O

RE	O
-	O
AIM	O
includes	O
five	O
domains	O
:	O
(	O
1	O
)	O
Reach	O
,	O
the	O
proportion	O
of	O
the	O
targeted	O
population	O
willing	O
to	O
participate	O
in	O
the	O
intervention	O
;	O
(	O
2	O
)	O
Effectiveness	O
,	O
the	O
impact	O
of	O
the	O
intervention	O
on	O
key	O
outcomes	O
;	O
(	O
3	O
)	O
Adoption	O
,	O
the	O
proportion	O
of	O
organizations	O
and	O
individuals	O
within	O
organizations	O
who	O
are	O
willing	O
to	O
initiate	O
the	O
intervention	O
within	O
their	O
setting	O
;	O
(	O
4	O
)	O
Implementation	O
,	O
the	O
fidelity	O
and	O
cost	O
of	O
delivery	O
at	O
the	O
setting	O
level	O
;	O
and	O
(	O
5	O
)	O
Maintenance	O
,	O
the	O
extent	O
to	O
which	O
the	O
intervention	O
is	O
sustained	O
over	O
the	O
longer	O
term	O
at	O
the	O
setting	O
and	O
individual	O
levels	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
prevalent	O
contextual	O
factors	O
that	O
may	O
have	O
influenced	O
outcomes	O
within	O
each	O
RE	O
-	O
AIM	O
domain	O
.	O

Methods	O

Study	O
design	O

The	O
current	O
study	O
focuses	O
specifically	O
on	O
implementation	O
experiences	O
within	O
a	O
pragmatic	O
hybrid	O
III	O
effectiveness	O
-	O
implementation	O
trial	O
of	O
VA	O
-	O
DPP	O
compared	O
to	O
MOVE	O
!	O
within	O
three	O
medical	O
centers	O
[	O
31	O
].	O

This	O
type	O
of	O
study	O
has	O
a	O
primary	O
focus	O
on	O
implementation	O
but	O
also	O
evaluates	O
clinical	O
outcomes	O
[	O
37	O
]	O
that	O
were	O
reported	O
elsewhere	O
[	O
34	O
].	O

This	O
paper	O
reports	O
quantitative	O
and	O
qualitative	O
findings	O
related	O
to	O
implementation	O
.	O

This	O
evaluation	O
was	O
approved	O
by	O
five	O
Institutional	O
Review	O
Boards	O
(	O
IRBs	O
)	O
for	O
each	O
of	O
the	O
five	O
research	O
institutions	O
involved	O
in	O
the	O
evaluation	O
(	O
three	O
demonstration	O
sites	O
,	O
one	O
national	O
coordinating	O
center	O
,	O
and	O
one	O
research	O
collaboration	O
site	O
).	O

Interventions	O

Details	O
about	O
the	O
programs	O
evaluated	O
are	O
provided	O
elsewhere	O
[	O
31	O
,	O
34	O
].	O

Briefly	O
,	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!	O
were	O
group	O
-	O
based	O
lifestyle	O
interventions	O
.	O

Each	O
VA	O
-	O
DPP	O
was	O
a	O
12	O
-	O
month	O
program	O
with	O
22	O
planned	O
sessions	O
delivered	O
by	O
a	O
single	O
CDC	O
-	O
certified	O
coach	O
in	O
closed	O
cohorts	O
(	O
i	O
.	O
e	O
.,	O
participants	O
started	O
and	O
finished	O
the	O
program	O
with	O
the	O
same	O
group	O
).	O

MOVE	O
!	O
was	O
an	O
8	O
-	O
10	O
-	O
week	O
program	O
followed	O
by	O
monthly	O
maintenance	O
sessions	O
delivered	O
in	O
open	O
cohorts	O
(	O
i	O
.	O
e	O
.,	O
participants	O
started	O
the	O
program	O
at	O
any	O
time	O
in	O
two	O
of	O
three	O
sites	O
)	O
by	O
a	O
multi	O
-	O
disciplinary	O
team	O
.	O

Implementation	O
approach	O

The	O
VA	O
-	O
DPP	O
implementation	O
strategy	O
was	O
guided	O
by	O
the	O
Simpson	O
et	O
al	O
.	O
program	O
change	O
model	O
[	O
31	O
,	O
38	O
].	O

First	O
,	O
each	O
site	O
’	O
s	O
clinical	O
champion	O
worked	O
to	O
elicit	O
site	O
leadership	O
commitment	O
,	O
documented	O
by	O
a	O
formal	O
memorandum	O
of	O
understanding	O
(	O
MOU	O
).	O

Second	O
,	O
VA	O
-	O
DPP	O
coaches	O
and	O
team	O
members	O
were	O
trained	O
by	O
the	O
Diabetes	B-DS
Prevention	O
Support	O
Center	O
(	O
DPSC	O
)	O
[	O
39	O
,	O
40	O
].	O

Third	O
,	O
each	O
site	O
adapted	O
a	O
protocol	O
to	O
implement	O
VA	O
-	O
DPP	O
,	O
with	O
special	O
focus	O
on	O
how	O
it	O
would	O
interface	O
with	O
MOVE	O
!	O

[	O
13	O
,	O
31	O
].	O

Similar	O
to	O
other	O
published	O
implementation	O
studies	O
[	O
41	O
],	O
coordinating	O
center	O
staff	O
ensured	O
a	O
uniform	O
approach	O
was	O
followed	O
across	O
the	O
sites	O
,	O
assisted	O
with	O
planning	O
and	O
problem	O
-	O
solving	O
,	O
and	O
helped	O
to	O
obtain	O
and	O
manage	O
MOUs	O
and	O
IRB	O
approvals	O
.	O

Assessment	O
of	O
outcomes	O
in	O
RE	O
-	O
AIM	O
domains	O

Multiple	O
data	O
sources	O
(	O
e	O
.	O
g	O
.,	O
staff	O
interviews	O
,	O
site	O
visits	O
,	O
participant	O
questionnaires	O
)	O
and	O
data	O
types	O
(	O
qualitative	O
,	O
quantitative	O
)	O
were	O
used	O
to	O
assess	O
barriers	O
and	O
facilitators	O
that	O
affected	O
RE	O
-	O
AIM	O
domains	O
,	O
as	O
well	O
as	O
fidelity	O
,	O
participant	O
satisfaction	O
,	O
and	O
cost	O
.	O

Additional	O
details	O
are	O
provided	O
in	O
the	O
following	O
sections	O
.	O

Barriers	O
and	O
facilitators	O
:	O
Reach	O
,	O
Effectiveness	O
,	O
Adoption	O
,	O
Implementation	O
,	O
and	O
Maintenance	O

Semi	O
-	O
structured	O
interviews	O
were	O
conducted	O
with	O
VA	O
-	O
DPP	O
team	O
members	O
during	O
the	O
early	O
stages	O
of	O
implementation	O
(	O
n	O
=	O
15	O
)	O
and	O
after	O
the	O
enrollment	O
ended	O
(	O
n	O
=	O
23	O
)	O
either	O
by	O
phone	O
or	O
face	O
to	O
face	O
during	O
site	O
visits	O
.	O

A	O
purposive	O
sample	O
of	O
other	O
site	O
staff	O
and	O
clinicians	O
was	O
also	O
asked	O
to	O
participate	O
in	O
interviews	O
.	O

Interview	O
guides	O
were	O
based	O
on	O
the	O
Consolidated	O
Framework	O
for	O
Implementation	O
Research	O
(	O
CFIR	O
)	O
and	O
are	O
published	O
elsewhere	O
[	O
31	O
].	O

The	O
CFIR	O
was	O
operationalized	O
as	O
a	O
codebook	O
for	O
qualitative	O
analysis	O
to	O
understand	O
how	O
contextual	O
factors	O
influence	O
RE	O
-	O
AIM	O
domains	O
[	O
31	O
].	O

The	O
CFIR	O
describes	O
39	O
constructs	O
across	O
five	O
domains	O
that	O
can	O
be	O
used	O
to	O
systematically	O
assess	O
and	O
articulate	O
contextual	O
factors	O
that	O
may	O
influence	O
program	O
implementation	O
:	O
(	O
1	O
)	O
intervention	O
characteristics	O
(	O
e	O
.	O
g	O
.,	O
adaptability	O
);	O
(	O
2	O
)	O
outer	O
setting	O
(	O
e	O
.	O
g	O
.,	O
external	O
policies	O
and	O
incentives	O
);	O
(	O
3	O
)	O
inner	O
setting	O
(	O
e	O
.	O
g	O
.,	O
leadership	O
engagement	O
);	O
(	O
4	O
)	O
individual	O
characteristics	O
(	O
e	O
.	O
g	O
.,	O
self	O
-	O
efficacy	O
);	O
and	O
(	O
5	O
)	O
process	O
(	O
e	O
.	O
g	O
.,	O
planning	O
)	O
[	O
42	O
].	O

All	O
interviews	O
were	O
audiorecorded	O
and	O
transcribed	O
verbatim	O
.	O

In	O
addition	O
,	O
site	O
visit	O
notes	O
,	O
meeting	O
minutes	O
,	O
and	O
emails	O
between	O
the	O
coordinating	O
center	O
and	O
sites	O
were	O
included	O
in	O
qualitative	O
analyses	O
to	O
provide	O
additional	O
information	O
about	O
ongoing	O
implementation	O
processes	O
.	O

Using	O
published	O
methods	O
[	O
43	O
],	O
two	O
analysts	O
independently	O
coded	O
and	O
assigned	O
ratings	O
based	O
on	O
qualitative	O
data	O
.	O

Differences	O
in	O
coding	O
and	O
rating	O
were	O
resolved	O
through	O
consensus	O
.	O

To	O
enable	O
comparison	O
within	O
and	O
between	O
sites	O
,	O
a	O
comprehensive	O
matrix	O
of	O
ratings	O
by	O
construct	O
and	O
site	O
was	O
developed	O
[	O
44	O
].	O

This	O
approach	O
identified	O
constructs	O
that	O
,	O
from	O
the	O
perspective	O
of	O
the	O
program	O
teams	O
,	O
influenced	O
implementation	O
outcomes	O
.	O

NVivo	O
®	O
Version	O
10	O
software	O
was	O
utilized	O
to	O
aid	O
coding	O
and	O
analysis	O
[	O
45	O
].	O

Delivery	O
fidelity	O

Corresponding	O
sessions	O
of	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!	O

(	O
two	O
sessions	O
from	O
each	O
program	O
with	O
similar	O
content	O
)	O
were	O
assessed	O
for	O
delivery	O
fidelity	O
.	O

At	O
each	O
site	O
,	O
the	O
VA	O
-	O
DPP	O
coordinator	O
or	O
other	O
team	O
member	O
attended	O
five	O
to	O
seven	O
sessions	O
and	O
used	O
a	O
pre	O
-	O
specified	O
checklist	O
to	O
rate	O
various	O
fidelity	O
domains	O
[	O
46	O
].	O

This	O
analysis	O
includes	O
fidelity	O
ratings	O
of	O
delivery	O
of	O
educational	O
content	O
,	O
review	O
of	O
goal	O
progress	O
,	O
goal	O
setting	O
,	O
group	O
cohesion	O
,	O
and	O
coaching	O
characteristics	O
(	O
managed	O
the	O
session	O
,	O
stayed	O
on	O
track	O
,	O
and	O
created	O
a	O
supportive	O
and	O
empathetic	O
environment	O
(	O
Table	O
1	O
)).	O

Previous	O
work	O
indicated	O
that	O
items	O
related	O
to	O
goal	O
progress	O
review	O
and	O
coach	O
delivery	O
characteristics	O
(	O
Table	O
1	O
)	O
were	O
associated	O
with	O
weight	O
loss	O
[	O
46	O
,	O
47	O
].	O

Raters	O
used	O
a	O
Likert	O
scale	O
(	O
1	O
=	O
strongly	O
disagree	O
to	O
7	O
=	O
strongly	O
agree	O
)	O
and	O
provided	O
optional	O
open	O
-	O
ended	O
comments	O
.	O

Factor	O
analyses	O
were	O
conducted	O
to	O
confirm	O
the	O
appropriate	O
groupings	O
of	O
items	O
within	O
domains	O
,	O
and	O
Cronbach	O
’	O
s	O
alpha	O
was	O
calculated	O
for	O
each	O
domain	O
to	O
determine	O
internal	O
reliability	O
.	O
T	O
tests	O
were	O
used	O
to	O
compare	O
mean	O
fidelity	O
ratings	O
between	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!.	O
Table	O
1VA	O
-	O
DPP	O
coordinator	O
ratings	O
of	O
fidelity	O
for	O
delivery	O
of	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!	O
VA	O
-	O
DPP	O
(	O
n	O
=	O
37	O
)	O
MOVE	O
!(	O
n	O
=	O
34	O
)	O
p	O
b	O
Questiona	O
Mean	O
(	O
SD	O
)	O
Delivery	O
of	O
educational	O
content	O
Coach	O
elicited	O
discussion	O
of	O
the	O
educational	O
content	O
in	O
order	O
to	O
help	O
participants	O
develop	O
a	O
self	O
-	O
management	O
skill	O
or	O
change	O
cognitions6	O
.	O
62	O
(	O
0	O
.	O
55	O
)	O
6	O
.	O
00	O
(	O
1	O
.	O
22	O
)	O
0	O
.	O
0094Goal	O
setting	O
,	O
Cronbach	O
’	O
s	O
alpha	O
=	O
0	O
.	O
66c	O
Type	B-DS
2	I-DS
diabetes	I-DS
prevention	O
was	O
discussed	O
as	O
a	O
goal	O
of	O
the	O
group4	O
.	O
59	O
(	O
2	O
.	O
20	O
)	O
1	O
.	O
97	O
(	O
1	O
.	O
70	O
)	O
0	O
.	O
0000	O
Coach	O
presented	O
standardized	O
goals	O
(	O
i	O
.	O
e	O
.,	O
everyone	O
had	O
the	O
same	O
goal	O
to	O
complete	O
the	O
following	O
week	O
)	O
to	O
the	O
participants	O
and	O
asked	O
them	O
to	O
commit	O
to	O
a	O
goal5	O
.	O
59	O
(	O
1	O
.	O
64	O
)	O
3	O
.	O
62	O
(	O
2	O
.	O
12	O
)	O
0	O
.	O
0001Review	O
of	O
goal	O
progress	O
,	O
Cronbach	O
’	O
s	O
alpha	O
=	O
0	O
.	O
94	O
Coach	O
prompted	O
review	O
of	O
goal	O
progress	O
and	O
attainmentd	O
6	O
.	O
41	O
(	O
0	O
.	O
86	O
)	O
4	O
.	O
76	O
(	O
2	O
.	O
31	O
)	O
0	O
.	O
0002	O
Coach	O
elicited	O
discussion	O
of	O
successes	O
and	O
challenges	O
since	O
the	O
last	O
sessiond	O
6	O
.	O
38	O
(	O
0	O
.	O
82	O
)	O
4	O
.	O
62	O
(	O
2	O
.	O
32	O
)	O
0	O
.	O
0001	O
Coach	O
initiated	O
problem	O
-	O
solving	O
when	O
necessary	O
to	O
address	O
challenges	O
since	O
the	O
last	O
sessiond	O
6	O
.	O
44	O
(	O
0	O
.	O
70	O
)	O
5	O
.	O
21	O
(	O
1	O
.	O
92	O
)	O
0	O
.	O
0008Group	O
cohesion	O
,	O
Cronbach	O
’	O
s	O
alpha	O
=	O
0	O
.	O
81	O
Group	O
identity	O
includes	O
having	O
a	O
diagnosis	O
of	O
prediabetes5	B-DS
.	O
21	O
(	O
1	O
.	O
63	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
90	O
)	O
0	O
.	O
0000	O
Group	O
members	O
communicated	O
easily	O
with	O
one	O
another6	O
.	O
10	O
(	O
1	O
.	O
22	O
)	O
5	O
.	O
35	O
(	O
1	O
.	O
57	O
)	O
0	O
.	O
0385	O
There	O
were	O
positive	O
relationships	O
among	O
the	O
group	O
members6	O
.	O
16	O
(	O
1	O
.	O
10	O
)	O
5	O
.	O
35	O
(	O
1	O
.	O
54	O
)	O
0	O
.	O
0184	O
Group	O
members	O
had	O
a	O
positive	O
attitude	O
toward	O
the	O
coach6	O
.	O
74	O
(	O
0	O
.	O
51	O
)	O
6	O
.	O
06	O
(	O
1	O
.	O
28	O
)	O
0	O
.	O
0056	O
Group	O
members	O
participated	O
actively	O
in	O
the	O
group6	O
.	O
41	O
(	O
0	O
.	O
74	O
)	O
5	O
.	O
59	O
(	O
1	O
.	O
58	O
)	O
0	O
.	O
0076Coach	O
characteristics	O
,	O
Cronbach	O
’	O
s	O
alpha	O
=	O
0	O
.	O
90Managed	O
the	O
session	O
Coach	O
came	O
prepared	O
and	O
organizedd	O
6	O
.	O
85	O
(	O
0	O
.	O
36	O
)	O
6	O
.	O
65	O
(	O
0	O
.	O
65	O
)	O
0	O
.	O
1091	O
Coach	O
elicited	O
clarification	O
of	O
participant	O
engagement	O
by	O
seeking	O
feedback	O
about	O
didactic	O
contentd	O
6	O
.	O
65	O
(	O
0	O
.	O
60	O
)	O
6	O
.	O
36	O
(	O
0	O
.	O
96	O
)	O
0	O
.	O
1510	O
Coach	O
delivered	O
didactic	O
material	O
in	O
an	O
engaging	O
,	O
matter	O
of	O
fact	O
,	O
and	O
respectful	O
wayd	O
6	O
.	O
79	O
(	O
0	O
.	O
41	O
)	O
6	O
.	O
65	O
(	O
0	O
.	O
69	O
)	O
0	O
.	O
2900	O
Coach	O
facilitated	O
discussion	O
and	O
interaction	O
using	O
open	O
-	O
ended	O
questions	O
,	O
affirmations	O
,	O
reflections	O
,	O
and	O
summariesd	O
6	O
.	O
53	O
(	O
0	O
.	O
61	O
)	O
6	O
.	O
26	O
(	O
0	O
.	O
96	O
)	O
0	O
.	O
1814	O
Coach	O
allocated	O
time	O
appropriately	O
in	O
order	O
to	O
cover	O
the	O
appropriate	O
content	O
focus	O
points	O
for	O
the	O
sessiond	O
6	O
.	O
62	O
(	O
0	O
.	O
65	O
)	O
6	O
.	O
47	O
(	O
0	O
.	O
99	O
)	O
0	O
.	O
4726	O
Coach	O
supplied	O
the	O
necessary	O
materials	O
for	O
the	O
participantsd	O
6	O
.	O
91	O
(	O
0	O
.	O
29	O
)	O
6	O
.	O
76	O
(	O
0	O
.	O
43	O
)	O
0	O
.	O
1026Stayed	O
on	O
track	O
Coach	O
addressed	O
process	O
(	O
tangential	O
)	O
issues	O
but	O
did	O
not	O
allow	O
them	O
to	O
disrupt	O
content	O
agendad	O
6	O
.	O
53	O
(	O
0	O
.	O
71	O
)	O
6	O
.	O
18	O
(	O
1	O
.	O
06	O
)	O
0	O
.	O
1105	O
Coach	O
avoided	O
delving	O
too	O
deeply	O
into	O
psychological	O
issuesd	O
6	O
.	O
74	O
(	O
0	O
.	O
51	O
)	O
6	O
.	O
50	O
(	O
0	O
.	O
71	O
)	O
0	O
.	O
1206Created	O
a	O
supportive	O
and	O
empathetic	O
environment	O
Coach	O
responded	O
empathetically	O
and	O
accurately	O
to	O
participant	O
behavior	O
(	O
verbal	O
,	O
nonverbal	O
)	O
d	O
6	O
.	O
85	O
(	O
0	O
.	O
36	O
)	O
6	O
.	O
59	O
(	O
0	O
.	O
61	O
)	O
0	O
.	O
0326	O
a1	O
=	O
strongly	O
disagree	O
to	O
7	O
=	O
strongly	O
agree	O
b	O
t	O
test	O
cFactor	O
analyses	O
were	O
conducted	O
to	O
confirm	O
the	O
appropriate	O
groupings	O
of	O
items	O
within	O
domains	O
;	O
Cronbach	O
’	O
s	O
alpha	O
was	O
calculated	O
for	O
each	O
domain	O
to	O
determine	O
internal	O
reliability	O
dItem	O
was	O
taken	O
from	O
published	O
fidelity	O
checklist	O
[	O
46	O
]	O

Participant	O
satisfaction	O

After	O
12	O
months	O
,	O
participant	O
perspectives	O
of	O
their	O
program	O
were	O
elicited	O
through	O
an	O
administered	O
survey	O
that	O
included	O
questions	O
about	O
program	O
satisfaction	O
(	O
Table	O
2	O
).	O
T	O
tests	O
compared	O
mean	O
ratings	O
between	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!.	O

All	O
analyses	O
were	O
conducted	O
using	O
Stata	O
13	O
[	O
48	O
].	O
Table	O
2Participant	O
program	O
satisfaction	O
at	O
12	O
months	O
(	O
N	O
=	O
260	O
)	O
Survey	O
questionVA	O
-	O
DPP	O
(	O
n	O
=	O
183	O
)	O
Mean	O
(	O
SD	O
)	O
MOVE	O
!(	O
n	O
=	O
77	O
)	O
Mean	O
(	O
SD	O
)	O
p	O
a	O
Group	O
preference	O
If	O
you	O
had	O
had	O
the	O
chance	O
to	O
switch	O
into	O
a	O
different	O
group	O
working	O
on	O
diet	O
and	O
exercise	O
,	O
how	O
would	O
you	O
have	O
felt	O
about	O
switching	O
?(	O
1	O
=	O
very	O
much	O
want	O
to	O
switch	O
,	O
5	O
=	O
very	O
much	O
want	O
to	O
stay	O
)	O
3	O
.	O
75	O
(	O
1	O
.	O
11	O
)	O
3	O
.	O
19	O
(	O
0	O
.	O
85	O
)	O
0	O
.	O
0005Group	O
cohesion	O
How	O
well	O
did	O
you	O
bond	O
with	O
your	O
group	O
members	O
?(	O
1	O
=	O
did	O
not	O
bond	O
,	O
2	O
=	O
bonded	O
a	O
little	O
,	O
3	O
=	O
bonded	O
very	O
well	O
)	O
2	O
.	O
45	O
(	O
0	O
.	O
65	O
)	O
2	O
.	O
20	O
(	O
0	O
.	O
80	O
)	O
0	O
.	O
0181Participant	O
satisfaction	O
with	O
coach	O
When	O
you	O
had	O
important	O
questions	O
to	O
ask	O
your	O
coach	O
,	O
did	O
you	O
get	O
answers	O
you	O
could	O
understand	O
?(	O
1	O
=	O
no	O
,	O
2	O
=	O
sometimes	O
,	O
3	O
=	O
always	O
)	O
2	O
.	O
82	O
(	O
0	O
.	O
44	O
)	O
2	O
.	O
80	O
(	O
0	O
.	O
41	O
)	O
0	O
.	O
7002	O
Did	O
you	O
feel	O
you	O
were	O
treated	O
with	O
respect	O
and	O
dignity	O
during	O
your	O
group	O
sessions	O
?(	O
1	O
=	O
no	O
,	O
2	O
=	O
sometimes	O
,	O
3	O
=	O
always	O
)	O
2	O
.	O
91	O
(	O
0	O
.	O
33	O
)	O
2	O
.	O
93	O
(	O
0	O
.	O
31	O
)	O
0	O
.	O
6653	O
Did	O
you	O
have	O
confidence	O
and	O
trust	O
in	O
your	O
coach	O
?(	O
1	O
=	O
no	O
,	O
2	O
=	O
sometimes	O
,	O
3	O
=	O
always	O
)	O
2	O
.	O
85	O
(	O
0	O
.	O
43	O
)	O
2	O
.	O
68	O
(	O
0	O
.	O
60	O
)	O
0	O
.	O
0233	O
Did	O
your	O
coach	O
provide	O
useful	O
suggestions	O
to	O
help	O
you	O
overcome	O
barriers	O
in	O
meeting	O
your	O
PA	O
goals	O
?(	O
1	O
=	O
no	O
,	O
2	O
=	O
sometimes	O
,	O
3	O
=	O
always	O
)	O
2	O
.	O
81	O
(	O
0	O
.	O
46	O
)	O
2	O
.	O
57	O
(	O
0	O
.	O
67	O
)	O
0	O
.	O
0036	O
Did	O
your	O
coach	O
provider	O
meaningful	O
feedback	O
regarding	O
your	O
progress	O
toward	O
meeting	O
your	O
goals	O
?(	O
1	O
=	O
no	O
,	O
2	O
=	O
sometimes	O
,	O
3	O
=	O
always	O
)	O
2	O
.	O
80	O
(	O
0	O
.	O
47	O
)	O
2	O
.	O
48	O
(	O
0	O
.	O
69	O
)	O
0	O
.	O
0002	O
My	O
coach	O
motivated	O
me	O
to	O
do	O
my	O
very	O
best	O
.(	O
1	O
=	O
strongly	O
disagree	O
,	O
5	O
=	O
strongly	O
agree	O
)	O
4	O
.	O
48	O
(	O
0	O
.	O
77	O
)	O
4	O
.	O
0	O
(	O
0	O
.	O
84	O
)	O
0	O
.	O
0001The	O
overall	O
response	O
rate	O
(	O
67	O
%)	O
was	O
similar	O
to	O
the	O
response	O
rate	O
from	O
VA	O
-	O
DPP	O
(	O
67	O
%,	O
n	O
=	O
183	O
)	O
and	O
MOVE	O
!	O

(	O
68	O
%,	O
n	O
=	O
77	O
).	O
aBased	O
on	O
t	O
tests	O
for	O
differences	O
between	O
MOVE	O
!	O
and	O
VA	O
-	O
DPP	O
fidelity	O
ratings	O
for	O
sample	O
of	O
sessions	O
delivered	O

Implementation	O
costs	O

Details	O
of	O
the	O
micro	O
-	O
costing	O
approach	O
used	O
are	O
described	O
elsewhere	O
[	O
32	O
].	O

Briefly	O
,	O
costs	O
of	O
implementing	O
VA	O
-	O
DPP	O
were	O
estimated	O
for	O
two	O
categories	O
:	O
(	O
1	O
)	O
recruiting	O
participants	O
and	O
implementing	O
VA	O
-	O
DPP	O
and	O
(	O
2	O
)	O
conducting	O
VA	O
-	O
DPP	O
sessions	O
.	O

VA	O
-	O
DPP	O
coordinators	O
and	O
coaches	O
at	O
each	O
site	O
recorded	O
time	O
spent	O
on	O
a	O
range	O
of	O
tasks	O
:	O
recruitment	O
,	O
administrative	O
tasks	O
,	O
team	O
meetings	O
,	O
session	O
preparation	O
,	O
and	O
session	O
delivery	O
.	O

Total	O
recruitment	O
time	O
was	O
multiplied	O
with	O
per	O
-	O
minute	O
wage	O
rates	O
to	O
derive	O
site	O
-	O
specific	O
total	O
cost	O
.	O

Total	O
costs	O
were	O
divided	O
by	O
the	O
number	O
assessed	O
and	O
enrolled	O
per	O
site	O
to	O
derive	O
per	O
participant	O
enrollment	O
cost	O
.	O

VA	O
-	O
DPP	O
sessions	O
included	O
costs	O
of	O
the	O
labor	O
inputs	O
and	O
participation	O
rates	O
associated	O
with	O
each	O
group	O
session	O
.	O

Appropriate	O
per	O
-	O
minute	O
wage	O
rates	O
were	O
applied	O
to	O
the	O
aggregated	O
activity	O
times	O
.	O

For	O
delivering	O
sessions	O
,	O
labor	O
cost	O
was	O
divided	O
by	O
the	O
number	O
of	O
participants	O
who	O
completed	O
each	O
session	O
.	O

Results	O

The	O
following	O
sections	O
describe	O
facets	O
of	O
the	O
RE	O
-	O
AIM	O
domains	O
that	O
were	O
evaluated	O
,	O
including	O
quantitative	O
measures	O
of	O
delivery	O
fidelity	O
,	O
participant	O
satisfaction	O
,	O
and	O
implementation	O
costs	O
.	O

Common	O
barriers	O
and	O
facilitators	O
were	O
evaluated	O
for	O
their	O
influence	O
on	O
each	O
of	O
the	O
RE	O
-	O
AIM	O
domains	O
.	O

Each	O
barrier	O
and	O
facilitator	O
is	O
demarcated	O
with	O
the	O
associated	O
CFIR	O
construct	O
(	O
in	O
parentheses	O
)	O
in	O
order	O
for	O
readers	O
to	O
easily	O
associate	O
findings	O
with	O
the	O
underlying	O
theoretical	O
framework	O
.	O

Because	O
findings	O
build	O
on	O
earlier	O
published	O
findings	O
,	O
there	O
are	O
additional	O
citations	O
to	O
integrate	O
the	O
rich	O
array	O
of	O
findings	O
.	O

Reach	O

Barriers	O
and	O
facilitators	O
:	O
recruitment	O
for	O
VA	O
-	O
DPP	O

As	O
reported	O
elsewhere	O
,	O
1830	O
individuals	O
attended	O
a	O
MOVE	O
!	O
orientation	O
session	O
,	O
and	O
21	O
%	O
were	O
eligible	O
for	O
the	O
study	O
[	O
13	O
,	O
34	O
].	O

Overall	O
,	O
11	O
%	O
were	O
women	O
and	O
48	O
%	O
were	O
a	O
racial	O
/	O
ethnic	O
minority	O
.	O

The	O
only	O
demographic	O
differences	O
between	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!	O
participants	O
were	O
related	O
to	O
race	O
/	O
ethnicity	O
;	O
there	O
were	O
higher	O
proportions	O
of	O
non	O
-	O
Hispanic	O
black	O
and	O
non	O
-	O
Hispanic	O
white	O
VA	O
-	O
DPP	O
participants	O
,	O
but	O
a	O
lower	O
proportion	O
of	O
Hispanic	O
participants	O
(	O
p	O
=	O
0	O
.	O
04	O
).	O

Recruitment	O
fell	O
far	O
short	O
of	O
the	O
targeted	O
sample	O
size	O
(	O
N	O
=	O
720	O
targeted	O
;	O
N	O
=	O
387	O
enrolled	O
;	O
N	O
=	O
386	O
in	O
final	O
analytic	O
sample	O
,	O
due	O
to	O
a	O
missing	O
weight	O
);	O
there	O
were	O
273	O
participants	O
assigned	O
to	O
VA	O
-	O
DPP	O
and	O
114	O
assigned	O
to	O
MOVE	O
!.	O

None	O
of	O
the	O
sites	O
achieved	O
their	O
recruitment	O
goal	O
due	O
to	O
several	O
barriers	O
.	O

A	O
process	O
to	O
systematically	O
identify	O
individuals	O
with	O
prediabetes	B-DS
did	O
not	O
exist	O
prior	O
to	O
VA	O
-	O
DPP	O
implementation	O
(	O
Negative	O
Compatibility	O
).	O

However	O
,	O
MOVE	O
!	O
had	O
an	O
existing	O
obesity	B-DS
screening	O
and	O
referral	O
process	O
in	O
place	O
;	O
VA	O
-	O
DPP	O
recruitment	O
relied	O
on	O
the	O
MOVE	O
!	O
referral	O
process	O
.	O

However	O
,	O
clinician	O
referrals	O
to	O
MOVE	O
!	O
were	O
lower	O
than	O
expected	O
in	O
all	O
three	O
sites	O
.	O

First	O
,	O
although	O
health	O
promotion	O
and	O
disease	O
prevention	O
was	O
a	O
high	O
priority	O
in	O
VHA	O
,	O
clinicians	O
felt	O
they	O
had	O
limited	O
time	O
to	O
discuss	O
weight	O
management	O
and	O
diabetes	B-DS
prevention	O
with	O
their	O
patients	O
.	O

Patients	O
frequently	O
presented	O
with	O
multiple	O
chronic	O
and	O
acute	O
conditions	O
which	O
were	O
a	O
more	O
immediate	O
medical	O
priority	O
(	O
Negative	O
Relative	O
Priority	O
).	O
They	O
don	O
’	O
t	O
have	O
time	O
for	O
[	O
prediabetes	B-DS
],	O
you	O
know	O
,	O
they	O
’	O
re	O
having	O
a	O
hard	O
-	O
enough	O
time	O
just	O
dealing	O
with	O
the	O
[	O
patients	O
with	O
]	O
out	O
of	O
control	O
diabetes	B-DS
]	O
[…],	O
it	O
’	O
s	O
the	O
old	O
story	O
about	O
when	O
you	O
’	O
re	O
killing	O
alligators	B-OG
,	O
it	O
’	O
s	O
hard	O
to	O
drain	O
the	O
swamp	O
(	O
Provider	O
).	O

Second	O
,	O
some	O
clinicians	O
did	O
not	O
believe	O
behavior	O
modification	O
programs	O
were	O
effective	O
for	O
their	O
patients	O
and	O
were	O
reluctant	O
to	O
refer	O
patients	O
(	O
Negative	O
Evidence	O
Strength	O
and	O
Quality	O
).	O
I	O
’	O
ve	O
heard	O
one	O
physician	O
who	O
’	O
s	O
pretty	O
vocal	O
at	O
the	O
meetings	O
say	O
,	O
“[	O
MOVE	O
!]	O
doesn	O
’	O
t	O
work	O
,	O
they	O
re	O
-	O
gain	O
the	O
weight	O
anyway	O
.”	O
A	O
couple	O
of	O
physicians	O
have	O
said	O
that	O
actually	O
.	O
“	O
Bariatric	O
surgery	O
’	O
s	O
the	O
only	O
thing	O
that	O
works	O
.”	O
So	O
I	O
don	O
’	O
t	O
know	O
that	O
they	O
even	O
believe	O
that	O
a	O
lifestyle	O
program	O
can	O
work	O
,	O
and	O
frankly	O
some	O
of	O
our	O
participants	O
do	O
well	O
but	O
a	O
lot	O
don	O
’	O
t	O
(	O
MOVE	O
!	O

Coordinator	O
).	O

Third	O
,	O
primary	O
care	O
clinics	O
at	O
the	O
three	O
sites	O
were	O
overwhelmed	O
by	O
the	O
major	O
reorganization	O
to	O
align	O
with	O
VA	O
’	O
s	O
version	O
of	O
PCMH	O
(	O
Negative	O
Relative	O
Priority	O
).	O

Fourth	O
,	O
one	O
site	O
had	O
no	O
formal	O
MOVE	O
!	O
referral	O
process	O
and	O
instead	O
,	O
patients	O
were	O
advised	O
by	O
their	O
primary	O
care	O
and	O
specialty	O
providers	O
to	O
schedule	O
a	O
MOVE	O
!	O
orientation	O
visit	O
during	O
the	O
check	O
-	O
out	O
process	O
.	O

This	O
may	O
have	O
reduced	O
one	O
barrier	O
(	O
not	O
requiring	O
a	O
provider	O
referral	O
)	O
but	O
introduced	O
another	O
when	O
patients	O
did	O
not	O
follow	O
up	O
(	O
Negative	O
Compatibility	O
).	O

In	O
addition	O
,	O
determining	O
eligibility	O
to	O
participate	O
in	O
VA	O
-	O
DPP	O
required	O
a	O
lab	O
or	O
point	O
-	O
of	O
-	O
care	O
(	O
POC	O
)	O
HbA1c	O
or	O
FPG	O
test	O
.	O

One	O
site	O
had	O
a	O
POC	O
testing	O
procedure	O
in	O
place	O
while	O
another	O
changed	O
their	O
electronic	O
health	O
record	O
(	O
EHR	O
)	O
to	O
prompt	O
clinicians	O
to	O
order	O
an	O
HbA1c	O
test	O
if	O
they	O
referred	O
a	O
participant	O
to	O
MOVE	O
!	O

(	O
Positive	O
Compatibility	O
).	O

The	O
third	O
site	O
did	O
not	O
have	O
either	O
process	O
in	O
place	O
;	O
VA	O
-	O
DPP	O
team	O
members	O
used	O
a	O
relatively	O
labor	O
-	O
intensive	O
process	O
that	O
involved	O
evaluation	O
based	O
on	O
EHR	O
data	O
or	O
ordering	O
a	O
new	O
HbA1c	O
lab	O
test	O
for	O
willing	O
individuals	O
(	O
Negative	O
Compatibility	O
).	O

Lastly	O
,	O
the	O
percentage	O
of	O
individuals	O
referred	O
to	O
MOVE	O
!	O
with	O
prediabetes	B-DS
was	O
lower	O
than	O
expected	O
;	O
prevalence	O
rates	O
for	O
normal	O
glycemic	O
status	O
,	O
prediabetes	B-DS
,	O
and	O
diabetes	B-DS
were	O
43	O
%	O
(	O
N	O
=	O
796	O
),	O
22	O
%	O
(	O
N	O
=	O
404	O
),	O
and	O
28	O
%	O
(	O
N	O
=	O
504	O
),	O
respectively	O
[	O
34	O
].	O

In	O
effect	O
,	O
most	O
patients	O
referred	O
to	O
MOVE	O
!	O
were	O
ineligible	O
because	O
they	O
did	O
not	O
meet	O
prediabetes	B-DS
criteria	O
,	O
which	O
further	O
contributed	O
to	O
unexpectedly	O
low	O
enrollment	O
.	O

Effectiveness	O

Barriers	O
and	O
facilitators	O
:	O
participation	O
and	O
attrition	O
in	O
VA	O
-	O
DPP	O

The	O
percentage	O
of	O
participants	O
who	O
attended	O
at	O
least	O
one	O
session	O
of	O
VA	O
-	O
DPP	O
was	O
higher	O
than	O
for	O
MOVE	O
!	O

(	O
73	O
.	O
3	O
vs	O
.	O
57	O
.	O
5	O
%;	O
p	O
=	O
0	O
.	O
002	O
).	O

Although	O
eligibility	O
for	O
VA	O
-	O
DPP	O
was	O
restricted	O
to	O
individuals	O
who	O
lived	O
within	O
60	O
min	O
of	O
their	O
sites	O
,	O
some	O
participants	O
still	O
had	O
transportation	O
barriers	O
(	O
Negative	O
Patient	O
Needs	O
and	O
Resources	O
):	O
I	O
think	O
it	O
’	O
s	O
hard	O
to	O
come	O
to	O
a	O
program	O
every	O
week	O
in	O
the	O
middle	O
of	O
the	O
day	O
.	O

[…]	O
[	O
Site	O
Three	O
]	O
is	O
5	O
miles	O
away	O
,	O
that	O
can	O
be	O
half	O
an	O
hour	O
or	O
45	O
minutes	O
and	O
that	O
’	O
s	O
not	O
a	O
doable	O
thing	O
for	O
most	O
people	O
(	O
Site	O
Investigator	O
).	O

Staff	O
interviews	O
revealed	O
additional	O
participation	O
challenges	O
such	O
as	O
time	O
conflicts	O
with	O
work	O
and	O
family	O
schedules	O
or	O
more	O
seriously	O
,	O
insecure	O
housing	O
,	O
unstable	O
employment	O
,	O
and	O
low	O
income	O
;	O
these	O
issues	O
were	O
more	O
common	O
for	O
participants	O
at	O
two	O
of	O
the	O
sites	O
and	O
affected	O
participation	O
in	O
both	O
MOVE	O
!	O
and	O
VA	O
-	O
DPP	O
.	O

VA	O
-	O
DPP	O
participants	O
also	O
remained	O
more	O
engaged	O
:	O
more	O
VA	O
-	O
DPP	O
participants	O
completed	O
at	O
least	O
four	O
sessions	O
compared	O
to	O
MOVE	O
!	O
participants	O
(	O
57	O
.	O
5	O
%	O
VA	O
-	O
DPP	O
;	O
42	O
.	O
5	O
%	O
MOVE	O
!,	O
p	O
=	O
0	O
.	O
007	O
)	O
and	O
more	O
VA	O
-	O
DPP	O
participants	O
completed	O
at	O
least	O
eight	O
sessions	O
compared	O
to	O
MOVE	O
!	O
participants	O
(	O
42	O
.	O
5	O
%	O
VA	O
-	O
DPP	O
;	O
31	O
%	O
MOVE	O
!,	O
p	O
=	O
0	O
.	O
035	O
)	O
[	O
34	O
].	O

VA	O
-	O
DPP	O
team	O
members	O
described	O
their	O
VA	O
-	O
DPP	O
participants	O
having	O
a	O
positive	O
experience	O
(	O
Positive	O
Patient	O
Needs	O
and	O
Resources	O
):	O
They	O
love	O
coming	O
to	O
class	O
,	O
they	O
like	O
being	O
around	O
each	O
other	O
,	O
they	O
like	O
hearing	O
from	O
each	O
other	O
,	O
they	O
like	O
encouraging	O
each	O
other	O
.	O

[…]	O
I	O
feel	O
like	O
overall	O
the	O
feedback	O
has	O
been	O
pretty	O
positive	O
(	O
VA	O
-	O
DPP	O
Coach	O
).	O

If	O
asked	O
,	O
the	O
MOVE	O
!	O
coordinators	O
may	O
have	O
offered	O
similar	O
statements	O
about	O
their	O
patients	O
having	O
positive	O
experiences	O
,	O
but	O
participant	O
-	O
reported	O
satisfaction	O
shows	O
differences	O
in	O
satisfaction	O
by	O
program	O
.	O

Of	O
the	O
387	O
participants	O
across	O
the	O
two	O
programs	O
,	O
286	O
(	O
74	O
%)	O
completed	O
satisfaction	O
questions	O
12	O
months	O
after	O
their	O
baseline	O
.	O

Participants	O
in	O
VA	O
-	O
DPP	O
reported	O
higher	O
levels	O
of	O
group	O
preference	O
(	O
p	O
=	O
0	O
.	O
0005	O
)	O
and	O
group	O
cohesion	O
(	O
p	O
=	O
0	O
.	O
0181	O
)	O
than	O
MOVE	O
!	O
participants	O
(	O
Table	O
2	O
).	O

They	O
also	O
reported	O
modestly	O
higher	O
satisfaction	O
with	O
their	O
coach	O
than	O
MOVE	O
!	O
participants	O
for	O
four	O
of	O
six	O
items	O
(	O
Table	O
2	O
).	O

Adoption	O

Barriers	O
and	O
facilitators	O
:	O
facility	O
adoption	O
of	O
VA	O
-	O
DPP	O

VA	O
-	O
DPP	O
site	O
leaders	O
were	O
familiar	O
with	O
the	O
evidence	O
base	O
for	O
VA	O
-	O
DPP	O
(	O
Positive	O
Evidence	O
Strength	O
and	O
Quality	O
),	O
which	O
helped	O
spark	O
initial	O
enthusiasm	O
for	O
having	O
the	O
program	O
at	O
their	O
sites	O
.	O

In	O
addition	O
,	O
these	O
leaders	O
acknowledged	O
the	O
benefits	O
of	O
targeting	O
and	O
engaging	O
high	O
-	O
risk	O
individuals	O
in	O
VA	O
-	O
DPP	O
(	O
Positive	O
Relative	O
Advantage	O
),	O
which	O
they	O
felt	O
their	O
existing	O
MOVE	O
!	O
program	O
did	O
/	O
could	O
not	O
do	O
.	O

However	O
,	O
one	O
site	O
leader	O
expressed	O
concerns	O
about	O
implementing	O
the	O
program	O
,	O
fearing	O
bureaucratic	O
challenges	O
such	O
as	O
hiring	O
new	O
staff	O
(	O
Negative	O
Structural	O
Characteristics	O
).	O

Ultimately	O
,	O
all	O
site	O
directors	O
signed	O
an	O
MOU	O
as	O
described	O
above	O
,	O
visibly	O
demonstrating	O
their	O
commitment	O
to	O
implementing	O
VA	O
-	O
DPP	O
(	O
Positive	O
Leadership	O
Engagement	O
).	O

In	O
addition	O
,	O
one	O
site	O
was	O
motivated	O
by	O
the	O
prospect	O
of	O
achieving	O
CDC	O
recognition	O
for	O
VA	O
-	O
DPP	O
[	O
32	O
],	O
while	O
another	O
was	O
motivated	O
by	O
the	O
enthusiastic	O
endorsement	O
of	O
a	O
national	O
-	O
level	O
political	O
leader	O
(	O
Positive	O
External	O
Policy	O
and	O
Incentives	O
).	O

Implementation	O

Fidelity	O
and	O
participant	O
satisfaction	O

VA	O
-	O
DPP	O
teams	O
rated	O
fidelity	O
of	O
program	O
delivery	O
for	O
71	O
sessions	O
(	O
37	O
sessions	O
for	O
VA	O
-	O
DPP	O
,	O
34	O
sessions	O
for	O
MOVE	O
!).	O

Fidelity	O
ratings	O
were	O
relatively	O
high	O
for	O
both	O
programs	O
(	O
Table	O
1	O
)	O
but	O
were	O
significantly	O
higher	O
for	O
VA	O
-	O
DPP	O
,	O
except	O
for	O
comparable	O
ratings	O
for	O
characteristics	O
of	O
the	O
coaches	O
leading	O
the	O
sessions	O
.	O

Cost	O

Costs	O
for	O
labor	O
to	O
recruit	O
participants	O
and	O
implement	O
VA	O
-	O
DPP	O
averaged	O
$	O
40	O
,	O
348	O
across	O
the	O
sites	O
($	O
35	O
,	O
283	O
–$	O
54	O
,	O
877	O
),	O
which	O
translated	O
to	O
$	O
68	O
($	O
46	O
–$	O
97	O
)	O
per	O
participant	O
assessed	O
and	O
$	O
330	O
($	O
210	O
–$	O
481	O
)	O
per	O
participant	O
identified	O
to	O
be	O
eligible	O
for	O
VA	O
-	O
DPP	O
.	O

Costs	O
related	O
to	O
scheduling	O
VA	O
-	O
DPP	O
group	O
sessions	O
,	O
sending	O
out	O
reminders	O
to	O
participants	O
,	O
and	O
preparing	O
for	O
sessions	O
averaged	O
$	O
28	O
,	O
462	O
across	O
the	O
sites	O
($	O
16	O
,	O
889	O
–$	O
49	O
,	O
680	O
),	O
which	O
translated	O
to	O
$	O
328	O
($	O
156	O
-$	O
591	O
)	O
per	O
participant	O
.	O

Costs	O
related	O
to	O
conducting	O
VA	O
-	O
DPP	O
sessions	O
averaged	O
$	O
101	O
per	O
group	O
session	O
conducted	O
($	O
64	O
–$	O
177	O
),	O
which	O
translated	O
to	O
a	O
total	O
cost	O
of	O
$	O
2220	O
($	O
1410	O
–$	O
3889	O
)	O
for	O
the	O
planned	O
22	O
sessions	O
for	O
VA	O
-	O
DPP	O
.	O

Participants	O
generated	O
,	O
on	O
average	O
,	O
57	O
completed	O
sessions	O
per	O
site	O
(	O
means	O
ranged	O
from	O
19	O
to	O
119	O
across	O
the	O
sites	O
);	O
it	O
cost	O
$	O
46	O
(	O
range	O
$	O
41	O
–$	O
60	O
)	O
per	O
participant	O
per	O
session	O
.	O

Barriers	O
and	O
facilitators	O
:	O
implementation	O
of	O
VA	O
-	O
DPP	O

A	O
strong	O
VA	O
-	O
DPP	O
team	O
at	O
each	O
site	O
supported	O
by	O
a	O
central	O
coordinating	O
center	O
was	O
the	O
single	O
most	O
important	O
facilitator	O
for	O
successful	O
implementation	O
(	O
Positive	O
Engaging	O
:	O
VA	O
-	O
DPP	O
Teams	O
;	O
Positive	O
Engaging	O
:	O
External	O
Change	O
Agent	O
).	O

Team	O
members	O
strongly	O
believed	O
in	O
VA	O
-	O
DPP	O
to	O
prevent	O
diabetes	B-DS
,	O
effectively	O
solved	O
problems	O
,	O
and	O
felt	O
a	O
strong	O
affinity	O
with	O
participants	O
(	O
Positive	O
Engaging	O
:	O
VA	O
-	O
DPP	O
Teams	O
).	O

In	O
addition	O
,	O
they	O
were	O
familiar	O
with	O
previous	O
DPP	O
study	O
findings	O
(	O
Positive	O
Evidence	O
Strength	O
and	O
Quality	O
)	O
and	O
believed	O
that	O
VA	O
-	O
DPP	O
had	O
advantages	O
over	O
MOVE	O
!	O

(	O
Positive	O
Relative	O
Advantage	O
).[	O
VA	O
-	O
DPP	O
]	O
really	O
focuses	O
specifically	O
on	O
diabetes	B-DS
prevention	O
,	O
and	O
not	O
just	O
weight	O
loss	O
in	O
general	O
,	O
and	O
I	O
think	O
those	O
are	O
[…]	O
two	O
separate	O
things	O
,	O
two	O
separate	O
goals	O
(	O
Site	O
Investigator	O
).	O

VA	O
-	O
DPP	O
teams	O
attended	O
a	O
2	O
-	O
day	O
training	O
delivered	O
by	O
the	O
DPSC	O
(	O
Positive	O
Access	O
to	O
Knowledge	O
and	O
Information	O
)	O
that	O
was	O
well	O
received	O
.	O
I	O
thought	O
[	O
the	O
DPSC	O
staff	O
members	O
]	O
were	O
excellent	O
presenters	O
,	O
just	O
very	O
impressed	O
…	O
I	O
was	O
hoping	O
to	O
get	O
them	O
[…]	O
out	O
here	O
to	O
do	O
a	O
workshop	O
for	O
us	O
.	O

That	O
’	O
s	O
how	O
effective	O
I	O
thought	O
they	O
were	O
(	O
VA	O
-	O
DPP	O
Coordinator	O
).	O

The	O
DPSC	O
also	O
provided	O
high	O
-	O
quality	O
materials	O
for	O
VA	O
-	O
DPP	O
teams	O
and	O
participants	O
(	O
Positive	O
Design	O
Quality	O
and	O
Packaging	O
).	O

Teams	O
were	O
further	O
supported	O
by	O
the	O
coordinating	O
center	O
(	O
Positive	O
Engaging	O
:	O
External	O
Change	O
Agent	O
),	O
which	O
hosted	O
bi	O
-	O
weekly	O
meetings	O
to	O
provide	O
new	O
information	O
and	O
reflect	O
on	O
progress	O
and	O
problem	O
-	O
solve	O
(	O
Positive	O
Access	O
to	O
Knowledge	O
and	O
Information	O
;	O
Positive	O
Reflecting	O
and	O
Evaluating	O
).	O

However	O
,	O
teams	O
encountered	O
several	O
challenges	O
.	O

Some	O
staff	O
outside	O
the	O
VA	O
-	O
DPP	O
team	O
perceived	O
VA	O
-	O
DPP	O
as	O
a	O
competitor	O
to	O
MOVE	O
!	O
and	O
questioned	O
whether	O
a	O
new	O
program	O
was	O
necessary	O
(	O
Negative	O
Compatibility	O
,	O
Negative	O
Relative	O
Advantage	O
).	O
If	O
people	O
are	O
prediabetic	O
,	O
losing	O
weight	O
will	O
help	O
decrease	O
their	O
risk	O
of	O
becoming	O
diabetic	O
,	O
so	O
MOVE	O
!	O
in	O
and	O
of	O
itself	O
could	O
serve	O
as	O
a	O
Diabetes	B-DS
Prevention	O
Program	O
,	O
although	O
it	O
’	O
s	O
not	O
called	O
that	O
(	O
MOVE	O
!	O

Coordinator	O
).	O

In	O
addition	O
,	O
sites	O
were	O
provided	O
funding	O
to	O
hire	O
staff	O
,	O
but	O
hiring	O
took	O
months	O
longer	O
than	O
expected	O
and	O
led	O
to	O
program	O
delays	O
(	O
Negative	O
Structural	O
Characteristics	O
).	O

However	O
,	O
as	O
one	O
VA	O
-	O
DPP	O
Coach	O
noted	O
,	O
space	O
was	O
“…	O
really	O
far	O
and	O
away	O
the	O
biggest	O
issue	O
.”	O
Sessions	O
were	O
rescheduled	O
or	O
canceled	O
when	O
the	O
rooms	O
were	O
needed	O
for	O
other	O
uses	O
.	O

Furthermore	O
,	O
VA	O
-	O
DPP	O
session	O
times	O
were	O
determined	O
by	O
available	O
space	O
,	O
not	O
by	O
convenience	O
for	O
participants	O
(	O
Negative	O
Available	O
Resources	O
).	O

Although	O
site	O
directors	O
signed	O
an	O
MOU	O
,	O
mid	O
-	O
level	O
managers	O
were	O
largely	O
disengaged	O
and	O
did	O
not	O
help	O
teams	O
resolve	O
hiring	O
or	O
space	O
issues	O
(	O
Negative	O
Leadership	O
Engagement	O
).	O

Lastly	O
,	O
VA	O
-	O
DPP	O
coaches	O
often	O
struggled	O
to	O
cover	O
all	O
the	O
content	O
specified	O
in	O
the	O
DPSC	O
facilitation	O
guides	O
within	O
hour	O
-	O
long	O
sessions	O
(	O
Negative	O
Design	O
Quality	O
and	O
Packaging	O
).	O

However	O
,	O
the	O
DPSC	O
team	O
clarified	O
that	O
coaches	O
had	O
latitude	O
to	O
adapt	O
content	O
to	O
the	O
needs	O
of	O
their	O
groups	O
(	O
Positive	O
Access	O
to	O
Knowledge	O
and	O
Information	O
;	O
Positive	O
Reflecting	O
and	O
Evaluating	O
).	O

Maintenance	O

Barriers	O
and	O
facilitators	O
:	O
maintenance	O
of	O
VA	O
-	O
DPP	O

Two	O
of	O
the	O
three	O
sites	O
continued	O
to	O
deliver	O
VA	O
-	O
DPP	O
as	O
a	O
separate	O
program	O
after	O
the	O
end	O
of	O
their	O
VA	O
-	O
DPP	O
demonstration	O
period	O
.	O

At	O
one	O
site	O
,	O
monthly	O
maintenance	O
sessions	O
were	O
held	O
after	O
participants	O
completed	O
12	O
months	O
of	O
VA	O
-	O
DPP	O
followed	O
by	O
two	O
separate	O
projects	O
focusing	O
on	O
peer	O
-	O
led	O
and	O
gender	O
-	O
specific	O
VA	O
-	O
DPP	O
implementation	O
.	O

One	O
site	O
did	O
not	O
sustain	O
VA	O
-	O
DPP	O
after	O
funding	O
ended	O
due	O
to	O
insufficient	O
resources	O
to	O
deliver	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!	O
concurrently	O
(	O
Negative	O
Available	O
Resources	O
).	O

At	O
the	O
national	O
level	O
,	O
however	O
,	O
NCP	O
leaders	O
recognized	O
the	O
early	O
improvements	O
in	O
outcomes	O
from	O
VA	O
-	O
DPP	O
compared	O
to	O
MOVE	O
!	O

[	O
34	O
]	O
(	O
Positive	O
Evidence	O
Strength	O
and	O
Quality	O
).	O

Subsequently	O
,	O
NCP	O
updated	O
guidance	O
for	O
MOVE	O
!	O
with	O
VA	O
-	O
DPP	O
features	O
thought	O
to	O
contribute	O
to	O
greater	O
weight	O
loss	O
(	O
Positive	O
Relative	O
Advantage	O
),	O
including	O
(	O
1	O
)	O
having	O
one	O
consistent	O
coach	O
to	O
lead	O
all	O
sessions	O
;	O
(	O
2	O
)	O
offering	O
closed	O
cohorts	O
;	O
(	O
3	O
)	O
providing	O
16	O
sessions	O
within	O
6	O
months	O
;	O
and	O
(	O
4	O
)	O
aligning	O
session	O
topics	O
more	O
closely	O
with	O
VA	O
-	O
DPP	O
topics	O
(	O
see	O
www	O
.	O
move	O
.	O
va	O
.	O
gov	O
/	O
grpSessions	O
.	O
asp	O
).	O

Discussion	O

The	O
challenge	O
of	O
implementing	O
complex	O
behavioral	O
programs	O
is	O
well	O
-	O
recognized	O
[	O
6	O
,	O
7	O
,	O
49	O
,	O
50	O
].	O

The	O
current	O
findings	O
point	O
to	O
the	O
need	O
for	O
multi	O
-	O
level	O
,	O
multi	O
-	O
component	O
strategies	O
that	O
include	O
,	O
for	O
example	O
,	O
maximizing	O
reach	O
by	O
carefully	O
integrating	O
processes	O
to	O
identify	O
high	O
-	O
risk	O
patients	O
and	O
engaging	O
primary	O
care	O
providers	O
.	O

Conducting	O
educational	O
outreach	O
and	O
attempting	O
to	O
heighten	O
clinical	O
priority	O
for	O
preventing	O
diabetes	B-DS
in	O
the	O
face	O
of	O
other	O
competing	O
demands	O
is	O
necessary	O
to	O
engage	O
providers	O
,	O
the	O
main	O
source	O
of	O
referrals	O
in	O
the	O
current	O
study	O
.	O

Many	O
efforts	O
to	O
vastly	O
scale	O
up	O
identification	O
of	O
high	O
-	O
risk	O
individuals	O
and	O
encourage	O
them	O
to	O
participate	O
in	O
DPP	O
-	O
like	O
programs	O
are	O
underway	O
in	O
other	O
countries	O
[	O
12	O
,	O
51	O
,	O
52	O
].	O

Lindstrom	O
and	O
colleagues	O
published	O
the	O
IMAGE	O
toolkit	O
,	O
motivated	O
by	O
the	O
premise	O
that	O
“	O
Small	O
changes	O
in	O
lifestyle	O
will	O
bring	O
big	O
changes	O
in	O
health	O
…	O
The	O
time	O
to	O
act	O
is	O
now	O
.	O

([	O
53	O
];	O
p	O
.	O

537	O
)”	O
These	O
motivating	O
words	O
are	O
aimed	O
at	O
aligning	O
partners	O
toward	O
a	O
common	O
high	O
-	O
priority	O
goal	O
around	O
diabetes	B-DS
prevention	O
.	O

The	O
toolkit	O
describes	O
foundational	O
principles	O
(	O
e	O
.	O
g	O
.,	O
engage	O
partners	O
from	O
multiple	O
strata	O
including	O
communities	O
)	O
and	O
functions	O
(	O
e	O
.	O
g	O
.,	O
reach	O
out	O
to	O
high	O
-	O
risk	O
individuals	O
).	O

The	O
CDC	O
also	O
developed	O
a	O
toolkit	O
for	O
implementation	O
[	O
54	O
].	O

Table	O
3	O
extends	O
these	O
recommendations	O
by	O
providing	O
potential	O
strategies	O
aimed	O
at	O
optimizing	O
outcomes	O
within	O
each	O
of	O
the	O
five	O
domains	O
of	O
RE	O
-	O
AIM	O
based	O
on	O
barriers	O
and	O
facilitators	O
shown	O
in	O
Fig	O
.	O
2	O
,	O
which	O
in	O
turn	O
reflect	O
the	O
experiences	O
at	O
the	O
three	O
study	O
sites	O
.	O

These	O
strategies	O
are	O
offered	O
as	O
hypotheses	O
to	O
be	O
tested	O
in	O
a	O
larger	O
trial	O
.	O
Table	O
3Recommended	O
strategies	O
to	O
address	O
organizational	O
level	O
barriers	O
as	O
described	O
by	O
RE	O
-	O
AIMDomainRecommendationsReach	O
targeted	O
participant	O
population	O
•	O
Design	O
referral	O
processes	O
that	O
are	O
(	O
1	O
)	O
compatible	O
and	O
integrated	O
with	O
existing	O
clinical	O
processes	O
;	O
(	O
2	O
)	O
effective	O
in	O
identifying	O
and	O
engaging	O
high	O
-	O
risk	O
participants	O
;	O
and	O
(	O
3	O
)	O
easy	O
to	O
use	O
•	O
Engage	O
clinicians	O
who	O
are	O
the	O
primary	O
source	O
of	O
referrals	O
through	O
personal	O
outreach	O
and	O
by	O
providing	O
easy	O
-	O
to	O
-	O
access	O
,	O
targeted	O
information	O
about	O
DPP	O
highlighting	O
its	O
(	O
1	O
)	O
evidence	O
base	O
,	O
(	O
2	O
)	O
compatibility	O
with	O
local	O
clinical	O
processes	O
,	O
(	O
3	O
)	O
advantages	O
compared	O
to	O
status	O
quo	O
,	O
and	O
(	O
4	O
)	O
organizational	O
and	O
clinical	O
priority	O
for	O
diabetes	B-DS
preventionEffectiveness	O
of	O
program	O
•	O
Schedule	O
sessions	O
at	O
a	O
time	O
and	O
place	O
convenient	O
for	O
participantsAdoption	O
by	O
clinical	O
settings	O
;	O
evidenced	O
by	O
visible	O
demonstration	O
of	O
commitment	O
by	O
executive	O
leaders	O
•	O
Target	O
education	O
and	O
information	O
to	O
executive	O
leadership	O
about	O
DPP	O
including	O
its	O
(	O
1	O
)	O
evidence	O
base	O
,	O
(	O
2	O
)	O
compatibility	O
with	O
clinical	O
processes	O
,	O
(	O
3	O
)	O
advantages	O
compared	O
to	O
the	O
status	O
quo	O
,	O
and	O
(	O
4	O
)	O
organizational	O
and	O
clinical	O
priority	O
to	O
inspire	O
them	O
to	O
adopt	O
the	O
program	O
•	O
Obtain	O
a	O
formal	O
agreement	O
(	O
e	O
.	O
g	O
.,	O
memorandum	O
of	O
understanding	O
),	O
signed	O
by	O
executive	O
leadership	O
,	O
to	O
commit	O
to	O
implement	O
DPPImplementation	O
with	O
consistency	O
(	O
track	O
costs	O
and	O
adaptations	O
)•	O
Target	O
education	O
and	O
information	O
to	O
mid	O
-	O
level	O
and	O
clinical	O
managers	O
about	O
DPP	O
including	O
its	O
(	O
1	O
)	O
evidence	O
base	O
,	O
(	O
2	O
)	O
compatibility	O
with	O
clinical	O
processes	O
,	O
(	O
3	O
)	O
advantages	O
compared	O
to	O
the	O
status	O
quo	O
,	O
and	O
(	O
4	O
)	O
organizational	O
and	O
clinical	O
priority	O
to	O
inspire	O
them	O
to	O
help	O
implementation	O
teams	O
solve	O
problems	O
and	O
review	O
progress	O
•	O
Ensure	O
adequate	O
time	O
to	O
hire	O
and	O
train	O
skilled	O
and	O
enthusiastic	O
implementation	O
leaders	O
and	O
coaches	O
to	O
deliver	O
DPP	O
•	O
Provide	O
high	O
-	O
quality	O
materials	O
to	O
coaches	O
and	O
participants	O
that	O
can	O
be	O
used	O
effectively	O
to	O
support	O
delivery	O
of	O
effective	O
coaching	O
during	O
sessions	O
(	O
e	O
.	O
g	O
.,	O
see	O
http	O
://	O
www	O
.	O
diabetesprevention	O
.	O
pitt	O
.	O
edu	O
/).•	O
Ensure	O
adequate	O
space	O
availability	O
for	O
sessions	O
•	O
Schedule	O
sessions	O
at	O
locations	O
and	O
times	O
that	O
are	O
convenient	O
to	O
participants	O
,	O
e	O
.	O
g	O
.,	O
in	O
community	O
settings	O
outside	O
of	O
normal	O
clinic	O
hoursMaintenance	O
of	O
DPP	O
in	O
the	O
clinical	O
setting	O
over	O
time	O
•	O
Effectively	O
report	O
on	O
outcomes	O
and	O
other	O
key	O
benefits	O
from	O
the	O
local	O
DPP	O
to	O
executive	O
leadership	O
,	O
managers	O
,	O
and	O
clinicians	O
(	O
especially	O
those	O
who	O
may	O
refer	O
their	O
patients	O
to	O
DPP	O
)	O
to	O
gain	O
support	O
for	O
the	O
program	O
and	O
build	O
a	O
robust	O
referral	O
network	O
Fig	O
.	O
2Conceptual	O
framework	O
:	O
integration	O
of	O
CFIR	O
contextual	O
factors	O
and	O
RE	O
-	O
AIM	O
domains	O

Within	O
VA	O
,	O
the	O
usual	O
care	O
MOVE	O
!	O
weight	O
management	O
program	O
can	O
prevent	O
incidence	O
of	O
diabetes	B-DS
[	O
5	O
,	O
55	O
].	O

It	O
is	O
a	O
relatively	O
low	O
-	O
intensity	O
program	O
with	O
no	O
diabetes	B-DS
risk	O
assessment	O
.	O

The	O
present	O
study	O
evaluated	O
a	O
higher	O
intensity	O
intervention	O
based	O
on	O
a	O
CDC	O
-	O
recognized	O
structured	O
curriculum	O
targeted	O
to	O
individuals	O
with	O
clinically	O
verified	O
prediabetes	B-DS
.	O

This	O
trial	O
shows	O
that	O
having	O
national	O
and	O
local	O
leaders	O
who	O
are	O
committed	O
to	O
diabetes	B-DS
prevention	O
is	O
a	O
necessary	O
,	O
though	O
far	O
from	O
sufficient	O
,	O
condition	O
for	O
successful	O
implementation	O
within	O
a	O
large	O
healthcare	O
system	O
.	O

Reaching	O
and	O
engaging	O
target	O
populations	O
is	O
a	O
universal	O
challenge	O
for	O
comprehensive	O
lifestyle	O
programs	O
across	O
settings	O
[	O
7	O
,	O
56	O
].	O

There	O
was	O
relatively	O
high	O
participation	O
in	O
this	O
trial	O
(	O
Fig	O
.	O
1	O
);	O
more	O
participants	O
assigned	O
to	O
VA	O
-	O
DPP	O
attended	O
at	O
least	O
one	O
session	O
compared	O
to	O
participants	O
assigned	O
to	O
MOVE	O
!.	O

In	O
addition	O
,	O
unlike	O
most	O
behavioral	O
intervention	O
studies	O
,	O
which	O
tend	O
to	O
over	O
-	O
represent	O
non	O
-	O
Hispanic	O
whites	O
[	O
57	O
],	O
48	O
%	O
of	O
VA	O
-	O
DPP	O
participants	O
identified	O
as	O
a	O
racial	O
/	O
ethnic	O
minority	O
(	O
compared	O
to	O
25	O
%	O
of	O
national	O
VHA	O
users	O
)	O
[	O
58	O
]	O
and	O
11	O
%	O
of	O
VA	O
-	O
DPP	O
participants	O
were	O
women	O
(	O
compared	O
to	O
8	O
%	O
of	O
national	O
VHA	O
users	O
[	O
59	O
]).	O

Robust	O
referral	O
processes	O
and	O
networks	O
to	O
identify	O
and	O
engage	O
participants	O
at	O
high	O
risk	O
are	O
essential	O
[	O
13	O
].	O

Once	O
high	O
-	O
risk	O
individuals	O
have	O
been	O
referred	O
,	O
scheduling	O
sessions	O
at	O
locations	O
and	O
times	O
that	O
are	O
convenient	O
to	O
participants	O
[	O
60	O
,	O
61	O
]	O
or	O
offering	O
online	O
programming	O
[	O
62	O
]	O
may	O
help	O
bolster	O
participation	O
.	O

The	O
single	O
largest	O
investment	O
incurred	O
for	O
the	O
VA	O
-	O
DPP	O
demonstration	O
was	O
the	O
total	O
average	O
$	O
40	O
,	O
348	O
per	O
site	O
to	O
assess	O
eligibility	O
and	O
implement	O
the	O
program	O
.	O

In	O
the	O
current	O
study	O
,	O
new	O
clinical	O
processes	O
had	O
to	O
be	O
designed	O
and	O
adapted	O
to	O
each	O
local	O
setting	O
to	O
accomplish	O
the	O
required	O
clinical	O
testing	O
of	O
HbA1c	O
or	O
FPG	O
levels	O
.	O

Several	O
countries	O
have	O
administered	O
short	O
self	O
-	O
assessment	O
risk	O
instruments	O
[	O
63	O
,	O
64	O
].	O

Individuals	O
at	O
high	O
risk	O
are	O
then	O
encouraged	O
to	O
enroll	O
in	O
a	O
nearby	O
community	O
-	O
based	O
DPP	O
-	O
like	O
program	O
.	O

The	O
later	O
the	O
risk	O
is	O
identified	O
,	O
the	O
more	O
intensive	O
the	O
intervention	O
should	O
be	O
[	O
65	O
].	O

The	O
current	O
study	O
used	O
more	O
intensive	O
risk	O
identification	O
based	O
on	O
clinical	O
testing	O
that	O
relied	O
on	O
preexisting	O
obesity	B-DS
treatment	O
referral	O
processes	O
already	O
in	O
place	O
.	O

This	O
approach	O
may	O
have	O
resulted	O
in	O
later	O
risk	O
identification	O
and	O
contributed	O
to	O
the	O
smaller	O
than	O
planned	O
sample	O
size	O
but	O
may	O
justify	O
the	O
more	O
intensive	O
DPP	O
.	O

Number	O
of	O
referrals	O
was	O
lower	O
during	O
the	O
demonstration	O
period	O
than	O
in	O
the	O
years	O
leading	O
up	O
to	O
the	O
demonstration	O
,	O
perhaps	O
because	O
of	O
other	O
organizational	O
priorities	O
during	O
that	O
time	O
(	O
e	O
.	O
g	O
.,	O
implementation	O
of	O
PCMH	O
during	O
the	O
demonstration	O
)	O
and	O
there	O
was	O
an	O
unexpectedly	O
high	O
prevalence	O
of	O
patients	O
who	O
already	O
progressed	O
to	O
diabetes	B-DS
,	O
especially	O
compared	O
to	O
the	O
general	O
VHA	O
patient	O
population	O
(	O
43	O
vs	O
.	O
25	O
%,	O
respectively	O
)	O
[	O
34	O
].	O

This	O
illustrates	O
the	O
potential	O
missed	O
opportunities	O
to	O
identify	O
and	O
engage	O
high	O
-	O
risk	O
individuals	O
before	O
they	O
progress	O
to	O
diabetes	B-DS
.	O

Additionally	O
,	O
VA	O
-	O
DPP	O
relied	O
on	O
primary	O
care	O
physicians	O
to	O
refer	O
patients	O
;	O
however	O
,	O
there	O
were	O
cases	O
where	O
physicians	O
did	O
not	O
believe	O
in	O
the	O
effectiveness	O
of	O
lifestyle	O
change	O
programs	O
for	O
their	O
patients	O
.	O

Few	O
studies	O
report	O
the	O
extent	O
to	O
which	O
DPP	O
is	O
delivered	O
as	O
designed	O
,	O
though	O
stated	O
use	O
of	O
a	O
standard	O
curriculum	O
is	O
a	O
recognized	O
contributor	O
to	O
greater	O
weight	O
loss	O
[	O
7	O
,	O
66	O
,	O
67	O
].	O

The	O
current	O
study	O
assessed	O
fidelity	O
of	O
delivery	O
.	O

Though	O
ratings	O
of	O
characteristics	O
of	O
the	O
coaches	O
delivering	O
each	O
of	O
the	O
programs	O
(	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!)	O
were	O
comparable	O
(	O
Table	O
1	O
),	O
VA	O
-	O
DPP	O
had	O
higher	O
fidelity	O
ratings	O
for	O
delivery	O
of	O
educational	O
content	O
,	O
goal	O
setting	O
,	O
review	O
of	O
goal	O
progress	O
,	O
and	O
group	O
cohesion	O
.	O

Reinforcing	O
this	O
finding	O
,	O
VA	O
-	O
DPP	O
participants	O
reported	O
higher	O
satisfaction	O
for	O
six	O
of	O
eight	O
program	O
characteristics	O
compared	O
to	O
MOVE	O
!.	O

Together	O
,	O
program	O
differences	O
in	O
fidelity	O
ratings	O
[	O
46	O
]	O
and	O
participant	O
satisfaction	O
helped	O
to	O
identify	O
factors	O
that	O
may	O
explain	O
higher	O
participation	O
rates	O
for	O
VA	O
-	O
DPP	O
compared	O
to	O
MOVE	O
!,	O
as	O
well	O
as	O
more	O
weight	O
loss	O
for	O
VA	O
-	O
DPP	O
,	O
[	O
6	O
,	O
7	O
]	O
at	O
least	O
in	O
the	O
short	O
term	O
.	O

It	O
is	O
not	O
clear	O
what	O
contributed	O
to	O
higher	O
delivery	O
fidelity	O
for	O
VA	O
-	O
DPP	O
compared	O
to	O
MOVE	O
!;	O
specific	O
characteristics	O
of	O
DPP	O
as	O
well	O
as	O
more	O
recent	O
training	O
of	O
DPP	O
coaches	O
may	O
have	O
contributed	O
to	O
this	O
difference	O
.	O

Although	O
there	O
were	O
no	O
statistical	O
differences	O
in	O
effectiveness	O
of	O
VA	O
-	O
DPP	O
versus	O
MOVE	O
!	O
at	O
12	O
months	O
(	O
3	O
.	O
4	O
vs	O
.	O
2	O
.	O
0	O
kg	O
lost	O
,	O
respectively	O
;	O
p	O
=	O
0	O
.	O
16	O
[	O
34	O
]),	O
the	O
lack	O
of	O
statistical	O
difference	O
between	O
groups	O
may	O
be	O
in	O
part	O
due	O
to	O
the	O
smaller	O
than	O
planned	O
sample	O
size	O
.	O

The	O
challenge	O
of	O
evaluating	O
implementations	O
of	O
complex	O
behavior	O
change	O
programs	O
like	O
DPP	O
is	O
well	O
-	O
recognized	O
[	O
68	O
].	O

Use	O
of	O
a	O
theoretical	O
framework	O
provides	O
concepts	O
and	O
language	O
that	O
can	O
be	O
expressed	O
consistently	O
across	O
diverse	O
studies	O
to	O
aid	O
comparisons	O
and	O
build	O
knowledge	O
about	O
complex	O
implementation	O
processes	O
[	O
42	O
,	O
69	O
].	O

Based	O
on	O
current	O
findings	O
,	O
Fig	O
.	O
2	O
posits	O
relationships	O
between	O
contextual	O
factors	O
and	O
domains	O
of	O
RE	O
-	O
AIM	O
based	O
on	O
common	O
barriers	O
and	O
facilitators	O
to	O
VA	O
-	O
DPP	O
implementation	O
.	O

These	O
relationships	O
are	O
offered	O
as	O
hypotheses	O
that	O
require	O
testing	O
in	O
other	O
settings	O
and	O
within	O
larger	O
-	O
scale	O
implementations	O
.	O

Multi	O
-	O
faceted	O
strategies	O
that	O
address	O
multiple	O
domains	O
of	O
context	O
are	O
needed	O
to	O
implement	O
DPP	O
in	O
a	O
way	O
that	O
maximizes	O
outcomes	O
within	O
each	O
RE	O
-	O
AIM	O
domain	O
(	O
Table	O
3	O
).	O

Though	O
DPP	O
has	O
been	O
shown	O
to	O
be	O
cost	O
-	O
effective	O
,	O
including	O
when	O
delivered	O
in	O
a	O
community	O
setting	O
[	O
70	O
,	O
71	O
],	O
health	O
system	O
and	O
policy	O
decision	O
-	O
makers	O
will	O
not	O
implement	O
programs	O
like	O
DPP	O
without	O
first	O
knowing	O
the	O
upfront	O
investment	O
and	O
ongoing	O
delivery	O
costs	O
.	O

Costs	O
to	O
deliver	O
VA	O
-	O
DPP	O
sessions	O
averaged	O
$	O
101	O
per	O
session	O
.	O

In	O
the	O
current	O
study	O
,	O
attendance	O
was	O
highly	O
variable	O
across	O
sites	O
,	O
across	O
cohorts	O
within	O
each	O
site	O
,	O
and	O
across	O
sessions	O
within	O
each	O
cohort	O
.	O

While	O
the	O
average	O
cost	O
per	O
participant	O
per	O
session	O
was	O
$	O
46	O
($	O
1012	O
for	O
22	O
sessions	O
)	O
for	O
VA	O
-	O
DPP	O
,	O
this	O
cost	O
could	O
be	O
as	O
low	O
as	O
$	O
12	O
per	O
participant	O
per	O
session	O
($	O
264	O
for	O
22	O
sessions	O
),	O
if	O
the	O
lowest	O
-	O
cost	O
site	O
($	O
1410	O
)	O
had	O
the	O
highest	O
observed	O
level	O
of	O
participation	O
(	O
119	O
).	O

This	O
cost	O
range	O
was	O
lower	O
than	O
cost	O
reported	O
for	O
the	O
original	O
DPP	O
(	O
estimated	O
costs	O
of	O
$	O
1399	O
per	O
person	O
in	O
the	O
first	O
year	O
)	O
[	O
71	O
]	O
and	O
are	O
similar	O
to	O
those	O
of	O
a	O
YMCA	O
group	O
-	O
based	O
DPP	O
(	O
estimated	O
costs	O
between	O
$	O
275	O
and	O
$	O
325	O
per	O
person	O
in	O
the	O
first	O
year	O
)	O
[	O
61	O
].	O

In	O
addition	O
,	O
administrative	O
tasks	O
related	O
to	O
preparing	O
for	O
each	O
VA	O
-	O
DPP	O
session	O
,	O
such	O
as	O
reminding	O
participants	O
to	O
attend	O
and	O
planning	O
the	O
session	O
,	O
which	O
averaged	O
$	O
328	O
per	O
participant	O
in	O
the	O
current	O
study	O
,	O
must	O
also	O
be	O
considered	O
when	O
allocating	O
staff	O
resources	O
.	O

It	O
is	O
important	O
to	O
note	O
limitations	O
in	O
this	O
evaluation	O
.	O

First	O
,	O
only	O
three	O
academically	O
affiliated	O
VHA	O
sites	O
participated	O
;	O
therefore	O
,	O
implementation	O
experiences	O
reported	O
may	O
be	O
unique	O
to	O
their	O
respective	O
settings	O
.	O

In	O
addition	O
,	O
the	O
study	O
occurred	O
during	O
an	O
organizational	O
transformation	O
to	O
the	O
VA	O
’	O
s	O
model	O
of	O
PCMH	O
within	O
the	O
primary	O
care	O
clinics	O
,	O
which	O
may	O
have	O
contributed	O
to	O
lower	O
than	O
expected	O
number	O
of	O
referrals	O
.	O

Second	O
,	O
fidelity	O
ratings	O
may	O
be	O
biased	O
positively	O
because	O
they	O
were	O
determined	O
by	O
VA	O
-	O
DPP	O
coordinators	O
/	O
coaches	O
who	O
rated	O
their	O
peers	O
.	O

However	O
,	O
this	O
bias	O
may	O
be	O
present	O
for	O
both	O
programs	O
because	O
VA	O
-	O
DPP	O
teams	O
worked	O
closely	O
with	O
MOVE	O
!	O
teams	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
comparison	O
of	O
ratings	O
for	O
VA	O
-	O
DPP	O
and	O
MOVE	O
!	O
was	O
limited	O
to	O
a	O
sample	O
of	O
program	O
sessions	O
and	O
delivery	O
components	O
at	O
these	O
sites	O
and	O
not	O
a	O
comprehensive	O
rating	O
for	O
all	O
aspects	O
of	O
all	O
sessions	O
.	O

Third	O
,	O
this	O
effort	O
was	O
done	O
as	O
part	O
of	O
an	O
effectiveness	O
-	O
implementation	O
hybrid	O
trial	O
.	O

National	O
partners	O
contributed	O
funding	O
for	O
the	O
clinical	O
teams	O
at	O
each	O
of	O
the	O
three	O
facilities	O
and	O
did	O
not	O
assess	O
diabetes	B-DS
incidence	O
or	O
clinical	O
measures	O
of	O
cardiovascular	B-DS
disease	I-DS
or	O
risks	O
.	O

When	O
funding	O
ended	O
,	O
two	O
of	O
the	O
three	O
sites	O
were	O
not	O
able	O
to	O
maintain	O
the	O
program	O
or	O
continue	O
screening	O
for	O
prediabetes	B-DS
.	O

A	O
strength	O
of	O
this	O
study	O
was	O
that	O
partners	O
and	O
local	O
leaders	O
deemed	O
local	O
activities	O
,	O
including	O
eligibility	O
screening	O
,	O
delivery	O
of	O
VA	O
-	O
DPP	O
,	O
and	O
outcome	O
assessments	O
as	O
part	O
of	O
a	O
clinical	O
quality	O
improvement	O
(	O
QI	O
)	O
initiative	O
that	O
required	O
no	O
additional	O
assessments	O
for	O
research	O
purposes	O
.	O

Patient	O
satisfaction	O
was	O
elicited	O
via	O
surveys	O
funded	O
by	O
research	O
.	O

IRB	O
approvals	O
included	O
use	O
of	O
data	O
collected	O
through	O
local	O
clinical	O
QI	O
activities	O
.	O

Fourth	O
,	O
an	O
economic	O
evaluation	O
of	O
usual	O
care	O
was	O
not	O
completed	O
and	O
intervention	O
impacts	O
on	O
blood	O
pressure	O
and	O
blood	O
cholesterol	O
were	O
not	O
assessed	O
.	O

Costs	O
were	O
estimated	O
for	O
eligibility	O
screening	O
,	O
implementation	O
,	O
and	O
delivery	O
of	O
only	O
DPP	O
.	O

Conclusions	O

The	O
comprehensive	O
qualitative	O
and	O
quantitative	O
findings	O
from	O
this	O
pragmatic	O
trial	O
of	O
VA	O
-	O
DPP	O
reveal	O
barriers	O
and	O
facilitators	O
that	O
influence	O
overall	O
program	O
success	O
.	O

Findings	O
suggest	O
a	O
number	O
of	O
strategies	O
that	O
may	O
help	O
support	O
future	O
real	O
-	O
world	O
implementations	O
of	O
DPP	O
,	O
including	O
gaining	O
visible	O
support	O
from	O
system	O
and	O
local	O
leaders	O
,	O
highlighting	O
the	O
evidence	O
base	O
and	O
benefits	O
of	O
DPP	O
for	O
key	O
stakeholders	O
including	O
referring	O
clinicians	O
,	O
and	O
providing	O
sufficient	O
time	O
and	O
resources	O
for	O
high	O
-	O
quality	O
staff	O
training	O
.	O

As	O
the	O
need	O
and	O
demand	O
for	O
DPP	O
increases	O
,	O
it	O
is	O
important	O
to	O
recognize	O
,	O
address	O
,	O
and	O
leverage	O
implementation	O
process	O
and	O
contextual	O
factors	O
that	O
contribute	O
to	O
maximum	O
success	O
of	O
DPP	O
.	O

